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GENERAL INTRODUCTION 
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For decades it was believed that the adult central nervous system 
(CNS) was a static network of cells and fibers without having the ability to 
reorganize neuronal communication. This belief was based on the 
assumption that changes in neurotransmission in the adult brain of higher 
vertebrates would interrupt the normal functioning of the brain and 
ultimately with physiological behavior. 
 
It is now well accepted that these adaptive processes, generally referred to 
as neuronal plasticity, take place in the adult mammalian CNS when for 
instance new skills and memories are acquired. These changes give the 
CNS the capability of adapting to the new environment at functional and 
structural levels. Likewise, when the brain is damaged by trauma or 
affected by neurodegenerative disease, mechanisms of plasticity play an 
important role to limit the amount of damage and to enhance recovery 
processes. Examples are sprouting or shrinkage of dendrites and axons, 
neurochemical changes in neurons and synapses, and even more 
remarkable the generation of new neurons and glia. 
 
In this thesis, we were mainly interested in the role of two monoaminergic 
neurotransmitters involved in neuronal plasticity: dopamine (DA) and 
General introduction 
 
4 
serotonin (5-hydroxytryptamine, 5HT). These neurotransmitters play a 
major role in subcellular, cellular and supracellular processes involved in 
behavioral functions. 
 
 
The brainstem serotonergic and dopaminergic neurons 
 
The region responsible for the main serotonergic innervation of the 
forebrain, involved in behavioral functions, is the dorsal raphe nucleus 
(DRN). The DRN is a large, distinct area situated in the brainstem 
tegmentum. It can be divided in four subdivisions: a dorsomedial cluster, a 
ventromedial division, the lateral sub nuclei (rostral subnucleus “B7”) and 
the caudal subnucleus (B6) (Steinbusch and Nieuwenhuys, 1982). The 
DRN compromises the largest cluster of 5-HT-containing nerve cell 
bodies in the mammalian CNS (Descarries et al., 1982). Besides 5-HT, the 
DRN also contains neuronal cells which use other neurotransmitters, e.g., 
γ-aminobutyric acid (GABA) (Nanopoulos et al., 1982), enkephalin 
(Hokfelt et al., 1979) and substance-p (Hokfelt et al., 1978). These 
neurons are known to innervate a great number of brain areas, e.g., the 
cerebral cortex (Yoshida et al., 1989), substantia nigra (SN) and the 
striatum (Vertes, 1991). Besides these ascending pathways, there are 
descending projections from the DRN, for instance to the locus coeruleus 
(LC) (Vertes and Kocsis, 1994) and cerebellum (Strazielle et al., 1996). 
The afferents of the DRN have been shown to originate from a great 
number of brain areas, e.g., cerebral cortex, the SN and the lateral 
habenular nucleus (LH) (Iversen and Iversen, 2007). Because the DRN is 
harboring a large subset of neurotransmitters and since it has a complex in 
and output pattern, the DRN is thought to participate in complex processes 
such as sensory perception, mood and affect, feeding and mating behavior, 
reward, sleep, aggression and cerebral blood flow (Mohammad-Zadeh et 
al., 2008). Because of its central position, it has also been implicated in 
different neurodegenerative diseases, e.g., Alzheimer disease (AD) 
(Michelsen et al., 2008) and Parkinson’s disease (PD) (Kaya et al., 2008). 
The main sources of DA in the mammalian brain, involved in 
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behavior, arise from two main groups of mesotelencephalic neurons 
designated as areas A9 and A10, according to Dahlstrom and Fuxe (1964). 
The A9 group corresponds to the substantia nigra pars compacta (SNc), 
whereas the A10 group is located in the ventral tegmental area (VTA). 
Based on the morphological and neurochemical properties, midbrain 
dopaminergic neurons are divided into dorsal and ventral portions. 
Neurons of the dorsal part, consisting of the dorsal parts of the SNc and 
VTA, are strongly immunoreactive for calbindin and have relatively low 
levels of TH and DA transporters. The neurons located in the ventral 
portions, however, do not express calbindin and exert high levels of 
immunoreactivity for DA transporters (Gerfen et al., 1985; Haber et al., 
1995). In rodents and primates it has been shown that, 50-70% of 
dopaminergic SNc and VTA neurons express calretinin (Isaacs and 
Jacobowitz, 1994; Rogers, 1992). In addition, a large proportion of 
dopaminergic neurons in the SNc and VTA are known to contain 
cholecystokinin and neurotensin (Crawley, 1991; Kalivas, 1985; Smith 
and Kieval, 2000). These regions are known to have reciprocal 
innervations with different brain regions including the neocortex, striatum 
and diencephalon (Haber and Fudge, 1997; Joel and Weiner, 2000). 
Beside these, the DRN is also known to contain dopaminergic neurons, 
which send efferent projections to different brain regions (Steinbusch et 
al., 1980; Stratford and Wirtshafter, 1990; Trulson et al., 1985). 
 
 
Neuroplasticity of the Serotonergic and Dopaminergic systems   
 
Regulation of many forms of neural plasticity is among the various 
functions of the neurotransmitters 5-HT and DA. The serotonergic system 
has plastic properties and plays a key role in the CNS homeostasis with the 
internal organs as well as the environment (Azmitia, 1999). It is well 
established that serotonergic fibers undergo degeneration and/or 
regeneration in different CNS areas (Frankfurt et al., 1985; Nobin et al., 
1973) under control of serotonergic neurons at distance (Igarashi et al., 
1995; Lima et al., 1994). Many studies have demonstrated that 5-HT 
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regulates the shape and patterns of neuronal connectivity (Azmitia et al., 
1996), synaptogenesis, (Azmitia et al., 1995; Chen et al., 1994; Okado et 
al., 1993), electrogenesis (Lessmann and Dietzel, 1991) and neurite 
outgrowth (Lieske et al., 1999), as well as survival of neuronal circuits and 
synapses in the adult brain (Moriizumi et al., 1994). In addition, there is 
increasing amount of evidence showing that the serotonergic system 
strongly controls neurogenesis in the neurogenic areas: the subgranular 
layer of the dentate gyrus of the hippocampal formations and the 
subventricular zone (Brezun and Daszuta, 1999; Cheng et al., 2010; 
Hitoshi et al., 2007; Momma et al., 2000).  
When it comes to the plasticity of the dopaminergic system, most of 
the studies have focused on short term and long term synaptic regulations 
such as long term potentiation (LTP) and long term depression (LTD). 
These changes can lead to different neurological abnormalities in motor 
performance, emotional states, and cognitive functions. However, more 
permanent forms of plasticity such as sprouting or synaptogenesis have 
been demonstrated as well (Davis et al., 2007). It has also been shown that 
the dopaminergic system can regulate the neurogenesis in adult brain 
(Baker et al., 2004; Hoglinger et al., 2004). In addition, DA regulates as an 
endogenous factor synaptic strength during the formation and maintenance 
of reactive plasticity following injury in the adult brain (Davis et al., 
2007). 
 
 
AIM OF THE PRESENT STUDY 
 
The aim of the studies presented in this thesis was to investigate the 
neuroplasticity of the serotonergic and dopaminergic systems in 
experimental and clinical models of pharmacological, genetic and 
electrical modulations. These investigations were performed using 
postmortem human brain tissues and genetically manipulated rodents. The 
aims of experiments are described in the following chapters.  
 
In Chapter 2, we used a pharmacological modulation model and 
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studied the intracellular content of 5-HT, DA and related neurotransmitters 
in the DRN. Chapter 3 aimed to find the consequence of genetic 
modulation on the serotonergic system in three different transgenic mouse 
models related to depression and anxiety. In Chapter 4, we continue with 
genetic modulation and investigate the change in the dopaminergic system 
within the different regions of the basal ganglia using the transgenic rat 
model of Huntington’s disease. Following this, Chapter 5 tests the 
hypothesis that an increased number of dopaminergic cells in the basal 
ganglia is due to the change in the phenotype of non-dopaminergic 
(serotonergic), again using models of genetic modulation. In Chapter 6, 
we review the involvement of serotonin in neurogenesis and provide an 
extensive review on the histology, anatomy, and chemistry of the 
subependymal serotonergic plexus.  
In Chapter 7 we use the electrical modulation model and report a 
novel method to deliver low electrical current to the motor cortex. Using 
this method we addressed the main hypothesis that neurogenesis is 
induced by chronic electrical stimulation of the brain and evaluated the 
involvement of the serotonergic system.  
Finally, in Chapter 8, we provide an overall conclusion of our 
findings.  
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CHAPTER 2 
 
 
Buspirone-induced changes in the serotonergic and non-
serotonergic cells in the dorsal raphe nucleus of rats  
 
Jahanshahi A, Lim LW, Steinbusch HW, Visser-Vandewalle V and Temel Y 
 
Abstract 
 
Buspirone, a 5-HT (5-hydroxytryptamine, serotonin) 1A partial 
agonist, is being used as an anxiolytic drug. The mechanism of action is 
explained by an effect on the 5-HT system. The main source of 5-HT in 
the forebrain is the dorsal raphe nucleus (DRN). However, there are also 
other populations of non-5-HT neurons in the DRN. Here, we investigated 
the effect of acute and chronic buspirone treatments on the 5-HT and non-
5-HT cells, the neuronal nitric oxide synthase (nNOS) and tyrosine 
hydroxylase (TH) cells, in the DRN. Rats received either an acute or 
chronic administration of buspirone or saline. Hereafter, the brains were 
processed for 5-HT, nNOS, and TH immunohistochemistry. We found that 
acute and chronic buspirone treatments significantly lowered the mean 
optical density of nNOS in the DRN as compared to controls. Meanwhile 
only the chronic buspirone treatment reduced the mean density of 5-HT 
and TH immunoreactivity but not the acute buspirone as compared to 
saline treated animals. Our findings suggest that buspirone treatment 
affects not only the intracellular content of 5-HT but also nNOS and TH. 
Therefore, the cellular effect of buspirone is more complex than thought. 
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Introduction 
 
Buspirone, a 5-HT (5-hydroxytryptamine, serotonin) 1A partial 
agonist, is used to treat generalized anxiety disorder clinically (Goodman, 
2004; Kane et al., 2002) and has profound effects on anxiety-related 
behavior in animal models (Lim et al., 2008b; Liu et al., 2007). At the 
cellular level, buspirone produces a dose-dependent reduction in the firing 
rate of 5-hydroxytryptamine (5-HT; serotonin) neurons in the dorsal raphe 
nucleus (DRN). The DRN is the major source of 5-HT in the forebrain 
(Stark et al., 2007). This inhibition is most probably mediated by the 
presynaptic (somatodendritic) 5-HT1A autoreceptors, similarly to the 
effect of selective serotonin reuptake inhibitors (Blier and Ward, 2003). It 
has been shown that systemic administration of 5-HT1A receptor agonist 
decreases the DRN 5-HT concentrations (Matos et al., 1996), and also a 
reduction in the number of c-fos immunoreactive cells in the DRN (Rioja 
et al., 2006). The therapeutic effect of buspirone is therefore, at least 
partially, mediated by modulating the 5-HT system. 
 
5-HT1A receptors are also present on dopaminergic cells, which are 
present in the DRN, and activation of them can inhibit dopamine (DA) 
synthesis (Johnson et al., 1993; Johnson et al., 1996). Nitric oxide (NO) 
containing cells are present in the DRN. NO synthase (NOS) has also been 
implicated in anxiety-like behavior (Faria et al., 1997; Garthwaite et al., 
1989; Garthwaite and Boulton, 1995). Interestingly, neuronal NOS 
(nNOS) is colocalized with 5-HT in some DRN neurons. Here, we have 
evaluated the effects of acute and chronic buspirone treatments on 5-HT 
containing, tyrosine hydroxylase containing, and nNOS containing cells in 
the DRN of rats with acute and chronic buspirone treatment.  
   
Experimental procedures  
 
Twenty-four male albino Wistar rats (Harlan, Horst, The 
Netherlands) weighing approximately 350-400g were used in this study. 
They were housed individually in standard transparent polypropylene 
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cages on sawdust bedding in an air-ventilated room under a 12/12-h 
reversed light/dark cycle with the room temperature at 20-22 °C and a 
humidity of 60-70%. Food, standard laboratory chow (Hopefarms, 
Woerden, the Netherlands), and water were available ad libitum. All 
animals were handled daily to habituate them. The experimental protocol 
was approved by the Animal Experiments and Ethics Committee of 
Maastricht University. 
 
Animals were divided randomly into the following four experimental 
groups: acute saline treatment (AS, n=5), acute buspirone treatment (AB, 
n=5), chronic saline treatment (CS, n=5), and chronic buspirone treatment 
(CB, n=5). Rats with acute treatment received only one injection, whereas 
the rats in the chronic treatment group were injected continuously for 
twenty one days with either saline or buspirone hydrochloride, 
respectively. 
 
Buspirone hydrochloride (TOCRIS Cookson Inc., Missouri, USA) 
was dissolved in saline solution and injected subcutaneously. A dose of 3 
mg/kg was used based on previous experiences (Hashimoto et al., 1992; 
Lim et al., 2008a; Lim et al., 2008b). One week before the actual 
experimental injection, all animals received 1 ml saline injection on 
alternating days to habituate the animals to the injection procedure. 
Chronic treatment with saline and buspirone consisted of 21 daily routine 
injections. The acute treatment with saline or buspirone (one time 
injection) was performed at day 21.  
 
At the end of the experiments, animals were deeply anesthetized 
with Nembutal (75 mg/kg) and perfused transcardially with Tyrode (0.1 
M) followed by fixative containing paraformaldehyde, picric acid and 
glutaraldehyde in phosphate buffer (pH 7.6). Brains were removed, post-
fixed and cryoprotected with sucrose treatment. Brain tissue was then 
quickly frozen with CO2 and stored at − 80 °C. Subsequently, the brains 
were cut serially on a cryostat into 30 μm frontal sections and again stored 
at −80 °C. One series was taken for 5-HT immunohistochemistry which 
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was carried out by using an anti-5-HT rabbit antibody (1:50000, kindly 
provided by Dr. HWM Steinbusch, Maastricht University, The 
Netherlands), diluted in 0.1% Bovine Serum Albumin (BSA) and Tris 
Buffered Solution (TBS)-Triton (TBS-T) solution. After three-night 
incubation, sections were incubated with the secondary antibody (donkey 
anti-rabbit biotine, Jackson Immunoresearch Laboratories Inc., Westgrove, 
USA) for 90 min. Meanwhile, another two series were also taken for 
nNOS (1:10000, rabbit anti-neuronal NOS, Sigma), and TH (1:100, mouse 
anti-TH antibody, kindly supplied by Dr. C. Cuello, Canada) 
immunohistochemistry. Both primary antibodies (nNOS and TH) were 
diluted in 0.1% Bovine Serum Albumin (BSA) and TBS-T solution, 
respectively. After an overnight incubation, sections were incubated with 
the secondary antibodies (donkey anti-rabbit biotine for nNOS sections, 
1:400, Jackson Immunoresearch Laboratories Inc., Westgrove, USA; and 
donkey anti-mouse for TH sections, 1:400, Jackson Immunoresearch 
Laboratories Inc., Westgrove, USA).  Subsequently, all 5-HT, TH, nNOS 
sections were incubated with an avidin-biotin-peroxidase complex (Elite 
ABC-kit, Vectastatin; Burlingame, USA) for 2 h, respectively. To 
visualize the immune complex of horseradish peroxide reaction product, 
sections were incubated with 3,3’-diaminobenzidine tetrahydrochloride/ 
nickel chloride solution. This reaction was stopped after 10 min by rinsing 
thoroughly all sections with TBS. All sections were then mounted, 
dehydrated, and coverslipped with Pertex (Histolab Products ab, Goteborg, 
Sweden).  
 
Results 
 
By qualitative examination, we observed marked differences in the 
optical density (OD = mean Gray value) of the 5-HT, TH and nNOS cells 
in the DRN of CB treated animals as compared to other groups. We 
measured the optical densities quantitatively. For this, the mean Gray 
values of respectively 20 5-HT, TH, and nNOS immunoreactive neurons 
in the DRN of each animal, were assessed at 40X magnification using an 
Olympus AX70 bright field microscope (analySIS; Imaging System, 
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Münster, Germany) connected to a digital camera (F-view; Olympus, 
Tokyo, Japan),. These neurons were selected from the same area in all 
animals (median part of the DRN). Each cell was analyzed using the 
Image J software (NIH, http://rsbweb.nih.gov/ij/) and the light intensity 
and threshold conditions were similar for all sections. The density of 
pixels ranged from 0 (black) to 255 (white) for an 8-bit digital signal.    
 
All data are presented as means ± S.E.M and were analyzed using a 
two-way Analysis of Variance (ANOVA) using Treatment (saline vs. 
buspirone) and Duration of Treatment (acute and chronic) as between-
subjects factors. All statistical analyses were performed with SPSS 16.0 
version for Windows. Fisher's Least Significant Difference (LSD) post hoc 
test was used to analyze group differences in more detail. P-values lower 
than 0.05 were considered significant.  
 
We found that acute and chronic buspirone treatment significantly 
lowered the OD of nNOS (P<0.001) in the DRN as compared to the saline 
groups. Only chronic buspirone treatment reduced the OD of 5-HT 
(P<0.001) and TH (P<0.01) cells when compared to the other groups.  
 
 
Figure1. The graphs represent means ± S.E.M. of animals treated with either saline 
or buspirone, acutely or chronically, respectively. (A) Mean gray value of 5-HT positive 
cells. (B) Mean gray value of nNOS positive cells. (C) Mean gray value of TH positive 
cells. * Indicates significant difference compared with saline treated animals.  
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Discussion 
 
Here, we have shown that CB treatment reduced the 
immunoreactivity level of 5-HT and TH in DRN cells, indicative of low 5-
HT and TH concentrations in the cells. Interestingly, the clinical anxiolytic 
effect of buspirone takes also place after 2 to 3 weeks (Goldberg and 
Finnerty, 1979; Rickels et al., 1982; Sramek et al., 2002). AB treatment 
had no effect on the OD of DRN 5-HT and TH containing cells. However, 
the OD of nNOS containing cells was decreased by both acute and chronic 
buspirone treatments. 
 
The effectiveness of CB treatment was also found in other 
experimental studies. CB administration (3 weeks) decreased the 5-HT1A 
receptor binding by approximately 25%-30% in the DRN (Sim-Selley et 
al., 2000). In addition, CB treatment decreased the 5-HT1A receptor 
immunoreactivity and 5-HT levels in the DRN (Khan and Haleem, 2006), 
as well as modulated 5-HT1A receptors in forebrain structures (Bosker et 
al., 1997; Ceci et al., 1994). Nevertheless, it is now becoming well-
established that the anxiolytic effect of CB administration depends on the 
DRN where the (somatodendritic) presynaptic 5-HT1A autoreceptors are 
located. Interestingly, a recent study by Nishi et al. (2009) using the 
animal model of “Flinders Sensitive Line”, demonstrated that CB 
treatment reduced 5-HT synthesis particularly in the DRN (Nishi et al., 
2009). Besides, electrophysiological studies showed that desensitization of 
5-HT1A autoreceptors in the DRN was also induced by chronic 
administration with analogues of buspirone, gepirone, and ipsapirone 
(Schechter et al., 1990). In view of these findings, CB treatment could 
eventually desensitize 5-HT1A autoreceptors by inhibiting 5-HT cell 
firing. However, on the basis of the current study, CB treatment probably 
enhances the bioavailability of 5-HT levels in the extracellular space by 
depleting the 5-HT content intracellularly.  
The present study demonstrated the decrease of OD of TH 
containing cells after chronic buspirone treatment, indicating a direct 
interaction of buspirone with DRN dopaminergic cells (Konig et al., 
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1988). Peroutka has shown in a radioligand binding study that buspirone 
displays a high affinity for 5-HT1A, D2 receptors, and moderate affinity 
for histamine, alpha-adrenergic2, and 5-HT2 receptors (Peroutka, 1985). It 
was previously reported that systemic administration of 5-HT1A receptor 
agonist 8-OH-DPAT increased acetylcholine release in the frontal cortex, 
and this effect of 8-OH-DPAT was then inhibited by the 5-HT1A 
antagonist WAY 100635 (Consolo et al., 1996; Somboonthum et al., 
1997). It is important to note that chronic treatment (14, 21 days) with 
citalopram, a selective serotonin reuptake inhibitor (SSRI) decreased the 
firing activity of noradrenergic (NA) neurons in locus coeruleus (LC) but 
not with the short-term treatment (Szabo et al., 2000). A wealth of 
evidence also showed that the NA neurons modulate the 5-HT system in 
the DRN that receive its projection from the LC (Baraban and Aghajanian, 
1980b; Clement et al., 1992). On the other hand, chronic systemic 
administration of mirtazapine, an α2-adrenergic antagonist increased the 
5-HT and NA neurons firing activity, indicating that this compound affects 
both the NA and 5-HT systems (Haddjeri et al., 1997). Other studies also 
demonstrated that SSRIs putatively involve in the NA system (Szabo et 
al., 1999; Szabo et al., 2000), that NA receptor antagonists directly 
influence the activity of DRN 5-HT neurons (Baraban and Aghajanian, 
1980a; Baraban and Aghajanian, 1980b; Costain and Green, 1978). Taken 
together, the latter studies have clearly shown that these two systems, 5-
HT and NA or dopamine, are remarkably interconnected in the 
pathophysiology of mood disorders; and it is of ultimate importance to 
understand the other neurotransmitter systems that act within this 
underlying mechanism. Several studies have reported the colocalisation of 
nNOS with 5-HT and TH containing cells in the DRN and other 
mesencephalic structures (Johnson and Ma, 1993; Kauffman et al., 1974; 
Panzica et al., 1996). It has been shown that approximately 70% of 5-HT 
neurons contain nNOS (Wotherspoon et al., 1994; Xu and Hokfelt, 1997), 
which allows NO to act as an intracellular messenger (Garthwaite, 1991; 
Vincent and Kimura, 1992). nNOS in DRN has been implicated in the 
regulation of sleep (Monti et al., 1999), conditioned fear (Grahn, 2000) 
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Figure 2. The figures represent high-power photomicrographs (40X) of a 30µm-think 
section from the DRN of animals treated with either acute or chronic saline/buspirone, 
respectively. Fig. 2 (A): 5-HT containing cells. Fig. 2 (B): nNOS containing cells. Fig. 2 
(C): TH containing cells. Note that effect of AB and CB treatment induced a remarkable 
reduction of optical density of nNOS containing cells; while only CB treatment decreased 
the optical density of 5-HT and TH containing cells. Optical density indication: the 
brightness of pixels ranged from 0 (black) to 255 (white) for an 8-bit digital signal. Scale 
bar: 50 µm. 
 
 
 
(Grahn et al., 2000),and mood and anxiety disorders (Guimaraes et al., 
2005; Spiacci et al., 2008). Interestingly, our findings of acute and chronic 
effects of nNOS, is in line with precious findings that this enzyme 
responsible for NO production is active in serotonergic cells during any 
moment of physiological response to the stimuli.   
 
In conclusion, we have shown that buspirone has an effect on 
different neurotransmitter systems in the DRN.  
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Abstract 
 
Depression and anxiety are among the leading causes of societal 
burden. Abnormalities in 5-hydroxytryptamine (5-HT; serotonin) 
neurotransmission are known to be associated with depressive and anxiety 
symptoms. The rostral projections of brainstem dorsal (DRN) and median 
(MRN) raphe nuclei are the main sources of forebrain 5-HT. The 
expression, turnover and distribution of tryptophan hydroxylase 2 (TPH2), 
the rate-limiting enzyme in 5-HT biosynthesis in the DRN and MRN are 
complex, in keeping with the existence of different subpopulations of 5-
HT neurons in this area. In the present study, we measured the expression 
of TPH2 mRNA in the DRN and MRN using in situ hybridization in three 
genetically modified mouse models, all relevant to depression and anxiety, 
and matched wild-type controls. Our results show quantitative 
modifications in TPH2 mRNA expression in the three main subregions of 
the DRN as well as the MRN in relation to changes in serotonergic, 
glutamatergic and endocannabinoid neurotransmission systems. Thus, 
there were significant decreases in TPH2 transcript levels in 5-HT 
transporter (5-HTT) -/- mutant mice, whereas increases were observed in 
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the vesicular glutamate transporter 1 hemi knock out (VGLUT1+/-) and 
cannabinoid receptor 1 mutant (CB1R-/-)mice.  
 
Based on these findings, we suggest that TPH2 mRNA expression is 
under the influence of multiple messenger systems in relation to 
presynaptic and/or postsynaptic feedback control of 5-HT synthesis that, 
5-HTT, VGLUT1 and CB1R seem to be involved in these feedback 
mechanisms. Finally, our data are in line with previous reports suggesting 
that TPH2 activity within different raphe subregions is differentially 
regulated under specific conditions. 
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Introduction 
 
Depression is a leading cause of disability worldwide and a serious 
health problem (Greenberg et al., 2003), but the exact mechanisms 
underlying its pathophysiology are still not well understood.  One line of 
evidence suggests that abnormalities in 5-hydroxytryptamine (5-HT; 
serotonin) neurotransmission are associated with depressive and anxiety 
symptoms (Cowen, 2008). 
 
The brainstem dorsal (DRN) and median (MRN) raphe nuclei, cell 
groups B7 and B8, respectively, according to Dahlström and Fuxe (1964), 
are the main source of forebrain serotonergic innervation and subsequently 
5-HT release (Steinbusch, 1981, 1984; Steinbusch and Nieuwenhuys, 1983; 
Michelsen et al., 2007, 2008). The DRN and MRN project heavily to 
several forebrain areas that modulate emotional and cognitive processes 
(Kosofsky and Molliver, 1987). The DRN can be subdivided anatomically 
into ventromedial (DRV) and dorsomedial (DRD) subregions over much 
of its length, and dorsolateral wings (DRL) in the mid-regions (Steinbusch 
et al., 1981a). Each of these subregions has been shown to project to 
specific parts of the cerebral cortex and subcortical regions, and 
consequently, may differentially regulate 5-HT neurotransmission 
(O'Hearn and Molliver, 1984; Steinbusch and De Vente, 1997). Moreover, 
these brainstem nuclei receive descending projections from forebrain 
regions such as prefrontal cortex (Hajos et al., 1998; Peyron et al., 1998; 
Celada et al., 2001). 
 
Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in 5-HT 
biosynthesis.  The discovery of a neuronal isoform, TPH2, by Walther and 
Bader (2003) opened up a new way to reliably map brain 5-HT neurons 
with immunohistochemistry and in situ hybridization. Results confirm a 
wide expression, including cell bodies in DRN and MRN (Zhang et al., 
2004; Clark et al., 2008). In fact, it is now established that TPH2 is the 
predominant isoform in the rodent brain (Gutknecht et al., 2008, 
Gutknecht et al., 2009). However, early studies have previously reported 
Altered expression of neuronal TPH2... 
 
 
32 
that TPH expression, turnover and distribution in DRN are complex, in 
line with the existence of different subpopulations of 5-HT neurons in this 
area (Weissmann et al., 1990).  
 
Changes in TPH2 gene and/or protein expression in the brain have 
been reported in various mood disorders and have been validated in animal 
models (Hiroi et al., 2006; Bach-Mizrachi et al., 2008, Bonkale and Austin, 
2008). TPH2 genetic variants have also been extensively reported to be 
associated with major depression (Zill et al., 2004; Van Den Bogaert et al., 
2006; Haghighi et al., 2008). However, whether these changes might 
reflect alterations in possible modulatory effects of other neurotransmitter 
systems on 5-HT systems is still largely unknown. To address this 
question directly, we measured TPH2 mRNA expression in three different 
transgenic mouse models, all related to pathological states of depression 
and anxiety, but caused by mutations affecting different neurotransmitter 
systems. 
 
One of the models is a 5-HT transporter-deficient mouse (5-HTT -/-) 
(Bengel et al., 1998; for review see Murphy and Lesch, 2008). By 
mediating the 5-HT reuptake in the nerve terminal (and other parts of the 
5-HT neuron), 5-HTT fine-tunes the magnitude and duration of 
serotonergic signaling (Canli and Lesch, 2007) which makes it the target 
for many antidepressant drugs, including the selective 5-HT reuptake 
inhibitors (SSRIs) (Owens and Nemeroff, 1998). They exhibit major 
adaptive changes in 5-HT neurotransmission, when compared with their 
wild-type controls. It has been shown that lack of 5-HTT depletes 5-HT 
and its metabolite 5-hydroxyindoleacetic acid by 60-80% in several brain 
areas such as the brainstem, striatum, hippocampus and frontal cortex 
(Bengel et al., 1998; Fabre et al., 2000). Functional desensitization of 5-
HT1A, 5-HT1B autoreceptors has been reported in the DRN of the 5-HTT 
-/- mutants as a consequence of high extracellular 5-HT levels in the 
vicinity of the serotonergic cells in the DRN. However, in terms of their 
target areas such as hippocampus and forebrain increased or no changes 
were observed in expression of these receptors. (Fabre et al., 2000; 
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Mannoury la Cour et al., 2001). Autoradiographic labeling of 5-HT2A 
receptors has also revealed a 30 to 40% reduction in the density of these 
receptors in the cerebral cortex and lateral striatum of 5-HTT-/- in 
comparison to the wild type mice (Rioux et al., 1999). In addition, 
anxiolytic- and antidepressant-like responses have been observed in 5HTT 
-/- mice in behavioral test paradigms such as the elevated plus maze, tail 
suspension and forced swim test (Holmes et al., 2003a; Holmes et al., 
2003b; Renoir et al., 2008). 
 
The second model consists of mice heterozygous for the vesicular 
glutamate transporter 1 (VGLUT1+/-) (Wojcik et al., 2004). As the first of 
three vesicular glutamate transporters (VGLUT1, VGLUT2 and VGLUT3) 
(Takamori et al., 2000), VGLUT1 has been shown to have a high level of 
expression in glutamatergic neurons in the cerebral cortex (Hisano, 2003). 
By concentrating glutamate in synaptic vesicles, VGLUT1 mediates 
glutamate release from synaptic terminals and facilitates efficient 
glutamatergic transmission (Fremeau et al., 2004; Wilson et al., 2005). 
Recent studies have demonstrated that VGLUT1+/- mice exhibit deficient 
glutamate transmission (Balschun et al., 2009), depressive-like behavior 
and neurochemical changes, which are related to depression and anxiety 
(Tordera et al., 2007; Garcia-Garcia et al., 2009). Aberrations in glutamate 
synthesis and its dysregulation also appear to play a relevant role in major 
depression (Krystal et al., 2002). In keeping with this, recent post-mortem 
studies showing decreased cortical VGLUT1 in depressed subjects 
(Uezato et al., 2009) together with clinical findings of an excitatory 
inhibitory imbalance in the cortex of depressed patients (Sanacora et al., 
2004; Bhagwagar et al., 2007) suggest that decreased VGLUT1 levels may 
have clinical implications. 
 
Finally, mice with targeted disruption of the gene encoding the 
cannabinoid 1 receptor (CB1R -/-) (Ledent et al., 1999) were used as an 
additional model of mood disorders. The endocannabinoid system is a 
major neuromodulatory system that contributes to the control of emotional 
behavior (Maldonado et al., 2006). The pharmacological and genetic 
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blockade of the CB1R induces a behavioral state analogous to depression 
in experimental animals (Hill and Gorzalka, 2005). Thus, CB1R -/- mice 
exhibit depressive-like symptoms, such as reduced responsiveness to 
reward stimuli (Sanchis-Segura et al., 2004; Maldonado et al., 2006) and 
enhanced anxiety levels and sensitivity to stress (Martin et al., 2002; Aso 
et al., 2008). Moreover, the chronic absence of CB1R activity induces 
alterations in 5-HT-dependent negative feedback. In particular, enhanced 
extracellular 5-HT levels in the prefrontal cortex decreased 5-HTT binding 
site density and caused functional desensitization of the 5-HT1A 
autoreceptors. As well reduced 5-HT2C receptor expression in different 
brain regions has previously been described in these mutants (Aso et al., 
2009). In addition, according to Mato et al., (2007) mice lacking CB1R 
exert impaired post-synaptic serotonergic signaling, suggesting that CB1R 
-/- mice are useful models to reveal more regarding the nature of 
cannabinoid-5-HT interactions in mood disorders. 
 
Experimental procedures 
 
Animals 
The experiments were carried out on 8–12- week-old male 5-HTT -/-, 
VGLUT1 +/- and CB1R -/- mice. Corresponding wild-type littermates 
were used as controls for each genetic model. All animals used in a given 
experiment were matched for age and weight. Mice were housed five per 
cage in a temperature (21 ± 1°C)- and humidity-controlled (55 ± 10 %) 
room with a 12:12-h light/dark cycle (light on 08:00) with food and water 
ad libitum. Animal procedures were conducted according to European 
ethical guidelines (European Communities Council Directive 86/609/EEC) 
and approved by the respective local Ethical Committees (PRBB) . 
 
Homozygous male 5-HTT -/- mice and wild-type (WT) littermates 
(obtained from Pierre & Marie Curie, Paris, France) born from 
heterozygous mutants at the tenth generation (F10) of backcrossing with 
C57BL/6J mice were used (Renoir et al., 2008). Genotyping was 
performed as described by Bengel et al. (1998).  
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Heterozygous VGLUT1 mice (VGLUT1+/-; C57BL/6N) were 
obtained from S. Wojcik (Göttingen, Germany). The targeted knockout 
allele was generated by truncation of the coding region of the VGLUT1 
gene between the start codon and a BglII site in the fifth coding exon 
through homologous recombination in embryonic stem cells (129/ola 
background). A colony of WT and VGLUT1 +/- mice was bred in the 
animal house of the University of Navarra from heterozygous fathers and 
WT mothers (Harlan, France). In this laboratory, mice were weaned and 
genotyped at the age of 3 weeks. The first heterozygous generation has 
already been bred for more than 20 generations in the C57BL/6N 
background. VGLUT1+/- mice were studied and compared to their WT 
littermates. Heterozygous mice exhibited no apparent phenotypic 
abnormalities during development and adulthood.   
 
Mice lacking CB1R (obtained from PRBB, Barcelona, Spain) were 
generated as previously described by Ledent et al. (1999). In order to 
obtain homogeneous genetic background, the first heterozygous 
generation was bred for 30 generations on a CD1 background, with 
selection for the mutant CB1R gene at each generation. After the 30th 
generation of backcross, heterozygote–heterozygote mating of CB1R 
knockout mice produced WT and CB1R -/- littermates for subsequent 
experiments. All mice were sacrificed between 9:00 and 10:00 am, 
alternating between WT and KO mice excluding all bias linked to the 
circadian cycle. Frozen brains from all three mouse models were sent on 
dry ice from the respective collaborating university to the Karolinska 
Institute (Stockholm). 
 
In situ hybridization 
 
Tissue preparation 
Mice were sacrificed by decapitation, and the brains were rapidly 
removed, frozen in isopentane and stored at -80 ºC until use. Mice 
brainstem were cut into 20 µm thick sections through the rostro-caudal 
extent of the DRN and MRN using cryostat, thaw-mounted on Superfrost 
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slides (Fisher Scientific) and stored at -20 ◦C. From the series of 50 
sections through the rostro-caudal extent of DRN and MRN, first of every 
four sections (12 in total) were subjected to in situ hybridization (ISH). 
Therefore, optical density measurements for each subregion were carried 
out using 12 sections taken from each brain and average value used for 
statistics. 
 
Oligoprobes 
Antisense oligoprobes complementary to mouse TPH2 mRNA 
(5’TCC GTC CAA ATG TTG TCA GGT GGA TCC AGC CTC ACA 
ATG GTG GTC3’, position 505; accession #NM-173391) were 
synthesized by CyberGene AB (Huddinge, Sweden). The oligonucleotides 
were labeled at the 3’ end using terminal deoxynucleotidyl-transferase 
(Amersham, Buckinghamshire, UK) with [α-33P] dATP (NEN, Boston, 
MA, USA) to a specific activity of 1-4 x 106 cpm/ng oligonucleotide. The 
labeled oligoprobes were purified using ProbeQuant G-50 Micro Columns 
(Amersham). Sections were hybridized as described previously (Schalling 
et al., 1988, Dagerlind et al., 1992). Briefly, air dried sections were 
incubated in a hybridization cocktail (50% formamide, 4xSSC, 
1xDenhardt’s solution 1% sarcosyl, 0.02 M phosphate buffer, PH 7.6,  10% 
dextran sulfate, 500 µg/ml heat-denatured salmon sperm DNA, 1x107 
cpm/ml of the labeled probe) in a humidified chamber for 16-18 h at 42 ºC. 
After hybridization, the sections were washed in 1xSSC for 4x15 min at 
55 ºC and for 30 min at RT, then air-dried and dipped into Kodak NTB 2 
emulsion (Kodak, Rochester, NY) diluted 1:1 with water. After exposure 
at 4 ºC for 72 h, the slides were developed in Kodak D19, fixed in Kodak 
Unifix and mounted in glycerol-phosphate buffer. For specificity control, 
adjacent sections were incubated with an excess (x100) of unlabelled 
probe. 
 
Quantitative analysis of the TPH2 mRNA expression levels in the 
dorsal and median raphe nuclei 
The expression levels of TPH2 mRNA in the DRD, DRV, DRL and 
MRN were quantified using an image analysis system (Nikon Microphot-
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MX microscope equipped with a dark-field condenser) from digital photos 
taken with a digital camera, DXM1200 (Nikon). Densitometric 
measurements (Image J software version 1.38x; NIH, Bethesda, USA) 
were obtained from the DRN after delineation of DRD, DRV and DRL 
and from the MRN based on a mouse brain atlas (Paxinos and Franklin, 
2001). The data are expressed as optical density ratios. 
 
 Statistical analyses 
For all experiments, samples from transgenic and wild type mice 
were treated in parallel. Data are presented as means and standard errors of 
means (S.E.M.). The quantitative data of the TPH2 mRNA expression 
levels in the DRD, DRV, DRL and the MRN were analyzed using two-
way ANOVA and statistically significant differences were evaluated 
further by a Tukey’s post hoc test. All statistical analyses were performed 
with SPSS 15.0 version for Windows. P-values lower than 0.05 were 
considered significant.   
 
In all of the experiments, there were no significant differences 
between the right and left sides of the DRL in any of the groups. Therefore, 
the data were pooled for these subregions. Note that the ISH for each 
strain of mice and corresponding controls was carried out independently at 
separate times. Therefore, the baseline of the optical density signal differs 
in different sets of experiments. 
 
 Results 
  
Decreased TPH2 mRNA expression in the dorsal and median 
raphe nuclei of mice deficient in 5-HT transporter 
 
Quantitative optical density measurements of in situ hybridization 
labeling showed that TPH2 mRNA expression was significantly decreased 
in the DRD and DRV subregions of the DRN as well as in the MRN 
(p<0.01, p<0.05 and p<0.05, respectively) of homozygous 5-HTT-/- mice 
(n= 4) compared with WT counterparts (n= 4). Although a decrease was 
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also noted in the DRL, the difference between 5-HTT -/- and WT 
genotypes did not reach the critical level of statistical significance in this 
DRN subregion (Figure 1).  
 
Enhanced TPH2 mRNA expression in the dorsal and median 
raphe nuclei of heterozygous VGLUT1+/- mice and CB1R knock out 
mutants 
 
A significant increase of TPH2 mRNA expression in the DRD, DRV, 
DRL and MRN (p<0.01, p<0.01, p<0.05 and p<0.05, respectively) was 
observed in VGLUT1 +/- mice (n= 4) in comparison to wild-type 
littermates (n= 3) (Figure 2). 
 
Similarly, ISH labeling of TPH2 mRNA in the DRD, DRV, DRL 
and MRN was at a significantly higher density (p<0.05) in homozygous 
CB1R -/- mutants (n= 5) than in paired wild-type controls (n= 5) (Figure 
3). 
Interestingly, in the three different lines of wild-type mice 
(C57BL/6J, C57BL/6N, CD1) investigated for these studies, the same 
heterogeneous distribution of TPH2 mRNA was observed within the DRN. 
Thus, in all cases, ISH labeling showed a higher (+10-40%) expression of 
TPH2 mRNA in the dorsomedial and ventromedial portions than in the 
dorsolateral portion of this region (Figures 1-3). Similar data have been 
previously reported in the rat (Clark et al., 2006). 
 
 
Discussion 
 
Using three genetically modified mouse models, all characterized by 
altered behaviors in depression-related paradigms, our results show 
quantitative differences in TPH2 mRNA expression in the three main 
subregions of the DRN as well as in the MRN. These changes are related 
to serotonergic or glutamatergic neurotransmission and to 
endocannabinoid systems. Thus, there were significant decreases in TPH2 
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mRNA expression in the 5-HTT-/- mutant mice, whereas increases in 
TPH2 mRNA expression were observed in the VGLUT1+/- and CB1R-/- 
mutant mice.  
 
 
 
Figure 1. A) Optical densitometry of TPH2 mRNA levels in the dorsomedial 
(DRD), ventromedial (DRV), and dorsolateral (DRL) parts of the dorsal raphe nucleus 
(DRN) and the median raphe nucleus (MRN) of wild-type (WT) controls and 5-HTT 
knock-out (5-HTT -/-) mice. B) Representative photomicrographs of 20 µm-thick 
sections at the level of the DRN and the MRN from a WT and a 5-HTT -/- mouse. Note 
that 5-HTT -/- mice show a reduction of TPH2 mRNA expression. Each bar is the mean 
+ S.E.M. from 4 mice of each genotype. scale bar: 500µm, *p < 0.05 and **p < 0.01. 
 
 
The 5-HTT -/- mouse 
It has previously been shown that TPH mRNA levels and activity 
can be regulated by the end-product 5-HT. For example, lower 5-HT 
levels result in higher TPH mRNA expression in vivo (Park et al., 1994). 
There is evidence that 5-HTT -/- mice exhibit marked changes in 5-HT 
synthesis and turn-over. In particular, lack of 5-HTT is associated with a 
60-80% depletion of 5-HT and its metabolite 5-hydroxyindoleacetic acid 
in several brain areas such as the brain stem, striatum, hippocampus and 
frontal cortex as compared with wild-type controls (Bengel et al., 1998; 
Fabre et al., 2000). Desensitization of 5-HT1A, 5-HT1B autoreceptors has 
been reported in 5-HTT -/- mutants as a consequence of high extracellular 
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5-HT levels in the DRN (Fabre et al., 2000; Mannoury la Cour et al., 
2001). Interestingly, such changes were also observed in mice after long-
term SSRI administration (Landgrebe et al., 2002), which are 
accompanied by decreased expression of TPH2 mRNA in DRN and MRN 
in rodents (Abumaria et al., 2007). In view of behavioral and biochemical 
evidence of similar alterations of serotonergic neurotransmission in mice 
lacking 5-HTT and in mice receiving long-term SSRI therapy, it can be 
proposed that high concentrations of 5-HT in the extracellular space of 5-
HTT-/- mice are also causally related to the reduced TPH2 mRNA 
expression in these mutants. Conversely, high TPH2 protein and mRNA 
levels have been reported in the DRN of depressed patients compared to 
control subjects, possibly due to a compensatory response to counteract 
deficits in extracellular 5-HT concentrations (Bach-Mizrachi et al., 2006). 
Increased TPH2 mRNA levels in the DRN have also been observed in rats 
after adverse experiences during early life and adulthood (Gardner et al., 
2009). However, further investigations are needed in order to elucidate the 
precise relationships between extracellular levels of 5-HT and TPH2 
mRNA expression because changes opposite to those noted above in 
SSRI-treated rodents (i.e., increased TPH2 mRNA expression) have also 
been reported (Shishkina et al., 2007).  
 
The lack of a significant decrease of TPH2 mRNA level in the DRL 
in 5HTT-/- mice in comparison with the other subregions of the DRN, 
known to contain fewer serotonergic neurons (Steinbusch, 1981), suggests 
that the DRL may be less involved in this model. In agreement with our 
data, previous studies already reported a heterogeneous distribution of 
TPH2 mRNA in the DRN with the greatest number of TPH2 mRNA-
positive neurons in the DRD and DRV subnuclei (Austin and O'Donnell, 
1999; Clark et al., 2006). Perhaps, the DRL exhibits a lower sensitivity to 
extracellular 5-HT levels and consequently does not display any alteration 
in TPH2 expression. Accordingly, changes in TPH2 expression in the 
ventromedial and dorsomedial DRN might play a more predominant role 
in modulating serotonergic neurotransmission and depressive behavior 
(Bonkale et al., 2006; Lowry et al., 2008). Nevertheless, it must be taken 
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in account that due to the sample sizes (n = 4) the statistical analysis might 
not have sufficient power to detect a decrease in TPH2 expression in the 
DRL of 5-HTT-/- mice. 
 
 
 
 
Figure 2. A) Optical densitometry of TPH2 mRNA levels in the dorsomedial 
(DRD), ventromedial (DRV), and dorsolateral (DRL) parts of the dorsal raphe nucleus 
(DRN) and the median raphe nucleus (MRN) of wild-type (WT) mice and paired 
heterozygous VGLUT1 +/- mice. B) Representative photomicrographs of the DRN and 
the MRN from a WT and a VGLUT1 +/- mouse. VGLUT1 +/- mice show increased 
TPH2 mRNA expression compared to WT. Each bar is the mean + S.E.M. of independent 
data obtained in 3-4 mice. scale bar: 500µm, *p < 0.05 and **p < 0.01. 
 
 
The VGLUT1 +/- mouse 
Alterations in glutamate and GABA neurotransmission appear to 
play a key role in depression (Krystal et al., 2002). In addition to high 
TPH2 mRNA levels in the raphe nuclei (Bach-Mizrachi et al., 2008), 
marked changes in glutamatergic and GABA-ergic neurotransmission 
have been observed in depressed patients, e.g., increased glutamate and 
decreased GABA at cortical and hippocampal levels (Bhagwagar et al., 
2007). However, the underlying molecular mechanisms responsible for the 
abnormal glutamate neurotransmission in the brain of depressed patients 
remain to be elucidated. 
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Interestingly, the VGLUT1+/- mice also exhibit changes in cortical 
and hippocampal release of glutamate and GABA together with increased 
anxiogenic/depressive-like responses (Tordera et al., 2007; Garcia-Garcia 
et al., 2009). VGLUT1 plays a critical role in refilling synaptic glutamate 
vesicles (Wilson et al., 2005; Takamori, 2006) and indeed, a recent study 
has demonstrated that VGLUT1+/- mice exhibit deficient glutamate 
transmission (Balschun et al., 2009). Moreover, the lack of VGLUT1 in 
glial cells also increases the probability of excitotoxic effects of excessive 
extracellular glutamate in brain, which in turn can lead to more disturbed 
glutamatergic neurotransmission (Valentine and Sanacora, 2009).      
 
The present study demonstrates that the glutamatergic system 
through VGLUT1 affects TPH2 mRNA expression. In particular, 
VGLUT1+/- mice exhibited increased TPH2 mRNA levels in the DRN 
and MRN that may be related to alterations in the 
glutamatergic/GABAergic-5-HT negative feedback system. Specifically, it 
has been established that forebrain glutamatergic neurons send projections 
to the ventral periaqueductal grey, stimulating local GABA neurons, 
which in turn inhibit 5-HT neurons (Arnsten and Goldman-Rakic, 1984; 
Sharp et al., 2007). Compromised glutamatergic signaling due to the 
reduced VGLUT1s in cortical prefrontal descending projections to the 
brainstem, as expected in VGLUT1+/- mice, would lead to attenuated 
stimulation of GABA neurons, and decreased inhibition of the 5-HT 
neurons and presumably, increased TPH2 mRNA levels. Moreover, the 
altered 5-HT function could contribute to explain the increased 
vulnerability of these mice to depressive like-behavior after exposure to 
chronic mild stress (Garcia-Garcia et al., 2009). With regard to the 
ascending component of the circuitry, 5-HT modulates the magnitude of 
responses in many cortical glutamatergic and GABA-ergic neurons 
(Araneda and Andrade, 1991; Aghajanian and Marek, 1999; Zhou and 
Hablitz, 1999). In addition, it has been reported that 5-HT controls, in turn, 
the activity of descending excitatory inputs through the activation of 
pyramidal cortical neurons (Amargos-Bosch et al., 2004). Since the 
neurochemical pathways regulating glutamate and GABA signaling are 
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closely related (Choudary et al., 2005), changes in the levels and the 
activity of these neurotransmitters can lead to altered excitation-inhibition 
ratios in the cortex (Bhagwagar et al., 2007).  
 
 
 
 
Figure 3. A) Optical densitometry of TPH2 mRNA levels in the dorsomedial 
(DRD), ventromedial (DRV), and dorsolateral (DRL) parts of the dorsal raphe nucleus 
(DRN) and the median raphe nucleus (MRN) in wild-type (WT) mice and paired CB1R 
knock-out (CB1R -/-). B) Representative photomicrographs at the level of DRN and 
MRN from a WT and a CB1R -/- mouse. A significant increase of TPH2 mRNA 
expression is observed in CB1R -/- compared to WT mice. Each bar is the mean + 
S.E.M. from 5 mice of each genotype. Scale bar: 500µm. *p < 0.05. 
 
 
The CB1R -/- mouse 
Previous evidence demonstrates that the endocannabinoid system 
through CB1R  regulates the activity of the serotonergic system by 
modulating different components of serotonergic feedback (Hill et al., 
2006; Bambico et al., 2007; Aso et al., 2009). In the present study, our 
data reveal additional alterations in the serotonergic activity at the levels 
of 5-HT synthesis in the absence of the CB1R. Mice lacking CB1R exhibit 
increased TPH2 mRNA expression in the MRN and all subregions of the 
DRN compared to wild-type littermates. Considering the role of TPH2 in 
5-HT synthesis and the reciprocal innervation between the prefrontal 
cortex and DRN (Jankowski and Sesack, 2004), the increased expression 
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of TPH2 in the DRN of CB1R -/- mice could contribute to the enhanced 
extracellular 5-HT levels in the prefrontal cortex of these mutants (Aso et 
al., 2009). Similarly, the alterations of different components involved in 5-
HT dependent negative feedback, such as enhanced extracellular 5-HT 
levels in the prefrontal cortex, decreased 5-HTT binding site density, 
functional desensitization of the 5-HT1A receptors and reduced 5-HT2C 
receptors have been described in CB1R-/- mice (Aso et al., 2009), as well 
as the enhancement of the 5-HT2A receptor excitatory effect on DRN and 
MRN produced by the lack of CB1R activity (Gorzalka et al., 2005), could 
also contribute to the increased 5-HT extracellular levels in the prefrontal 
cortex in CB1R-/- mutants. The synergistic alteration of these multiple 
serotonergic components modulated by CB1R on 5-HT signaling might be 
a reason for the robust up-regulation of TPH2 mRNA in all subregions of 
the DRN/MRN complex in CB1R-/- mice. 
In contrast to the expected consequence of the enhanced serotonergic 
release, the genetic and pharmacological blockade of the CB1R induces a 
depressive-like phenotype (Hill and Gorzalka, 2005). This could be 
explained by the impairment of other mechanisms controlling emotional 
homeostasis beyond 5-HT neurotransmission in the absence of CB1R, 
such as the effects of stress on glucocorticoids and neurotrophic factor 
levels (Aso et al., 2008). The alterations observed on 5-HT 
neurotransmission have been proposed to be a substrate for counteracting 
the stress-induced emotional impairment in mice lacking CB1R since 
similar changes have been described after antidepressant treatments 
(Lanfumey et al., 2000; Le Poul et al., 2000; Gould et al., 2006). 
Nevertheless, an impaired post-synaptic serotonergic signaling has been 
reported in CB1R-/- mice (Mato et al., 2007), which could lead to a 
reduction in the efficacy of 5-HT for ameliorating their depressive-like 
phenotype. 
 
Taken together, these data suggest that the CB1R gene knock out 
should lead to a reduction of the inhibitory effect exerted through 5-HT1A 
and 5-HT2C receptors and enhancement of the excitatory effect through 5-
HT2A receptors on DRN and MRN 5-HT neurons, possibly leading to 
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increased expression of TPH2 mRNA. Additionally, CB1R -/- mice are 
characterized by impaired serotonergic negative feedback (Aso et al., 
2009), and CB1R stimulation in the cortex directly inhibits 5-HT release 
(Nakazi et al., 2000), whereas a CB1R antagonist exerts the opposite 
effect (Tzavara et al., 2003). Therefore, changes in negative feedback 
input to the raphe nuclei from medial prefrontal cortex (Hajos et al., 1999) 
due to the absence of CB1R in DRN could compromise the feedback 
mechanisms in the raphe nuclei. The synergistic attenuation of the 
multiple actions mediated by CB1R on 5-HT signaling might be a reason 
why CB1R-/- mice show such a robust up regulation of TPH2 mRNA in 
all parts of the DRN/MRN complex. 
 
Conclusion  
In conclusion, based on the findings of the present study, we suggest 
that TPH2 mRNA expression is under the influence of multiple messenger 
systems in relation with presynaptic and/or postsynaptic feedback control 
of 5-HT synthesis. 5-HTT, VGLUT1 and CB1R seem to be involved in 
the execution of these feedback mechanisms. Finally, our data are 
consistent with previous reports suggesting that TPH2 activity within 
different raphe subregions are differentially regulated under specific 
conditions. 
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Abstract 
 
Huntington’s disease chorea has been linked to an increased 
dopaminergic neurotransmission in the striatum. In this respect, clinical 
studies have demonstrated that the chorea can be treated with dopamine 
antagonist or dopamine depleting drugs. However, the origin of this 
hyperdopaminergic status remains unknown. In a recently generated 
transgenic rat model of Huntington’s disease, which exhibits progressive 
striatal neurodegeneration and chorea, we have found evidence for 
increased levels of dopamine in the striatum which is in line with post-
mortem human studies. In addition, we have demonstrated that the origin 
of increased levels of dopamine is the presence of more dopaminergic 
cells in the ventral tegmental area and the substantia nigra pars compacta 
of transgenic Huntington’s disease rats, the two main nuclei providing the 
striatum with dopamine.  
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Introduction  
 
Huntington’s disease (HD) is an autosomal dominant inherited 
progressive neurodegenerative disorder (HuntingtonStudyGroup, 1993; 
Vonsattel and DiFiglia, 1998). The mutation involves the expansion of the 
CAG trinucleotide repeat within exon one of the HD gene on chromosome 
four. This mutation encodes an extended polyglutamine stretch in the N-
terminal domain of the huntingtin protein, whose function is actually still 
poorly understood (Bauer et al., 2005). Huntingtin accumulates in the 
brain and can have either toxic (Weiss et al., 2009; Yang et al., 2002) or 
protective effects (Ravikumar et al., 2004). The prevalence of HD in 
Europe and both American continents is reported to be approximately 1 in 
100,000 and affects both sexes with the same frequency (Walker, 2007). 
HD can become symptomatic in principle at any age, but the peak 
incidence is at mid-adult life.  
 
Histopathologically, HD is characterized by loss of striatal projection 
neurons, striatal interneurons being relatively spared, and striatal atrophy 
(Huot et al., 2007; Sharp et al., 1995; Vonsattel et al., 1985).  The striatal 
projection neurons, also known as medium spiny neurons, can be divided 
into two groups based on their connectivity and neurochemistry. 
Degeneration takes place in both populations, but the medium spiny 
neurons expressing the dopamine 2 (D2) receptors and enkephalin are 
more affected (Reiner et al., 1988). Besides the profound neuron death in 
the striatum (Levesque et al., 2003), the neuropathology of HD comprises 
atrophy of the cerebral cortex and thinning of the underlying white matter 
(Rosas et al., 2008). Neuronal loss in other brain structures such as the 
hippocampus, cerebellum and thalamus has been reported as well (de la 
Monte et al., 1988; Schmitz et al., 1999). 
 
Clinically, HD is characterized by motor and non-motor symptoms. 
The predominant motor symptom is the chorea, and to a lesser extent 
hypokinesia. The non-motor symptoms consist of cognitive dysfunction 
leading to dementia and emotional instability. The chorea can be defined 
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as an abrupt, rapid, brief, irregular and unsustained movement. The patho-
anatomical basis for the chorea is not well known, but a link with the 
dopaminergic system has been suggested by human post-mortem studies 
and clinical therapy studies. Early post-mortem studies showed that striatal 
dopamine levels, both in the dorsal and ventral striatum were significantly 
higher in HD patients compared to controls (Bird, 1980; Bird et al., 1980; 
Spokes, 1980). In addition, clinical studies have shown that the chorea can 
be treated with dopamine antagonist or dopamine depleting drugs (Mason 
and Barker, 2009).  
 
The origin of elevated dopamine levels in the dorsal and ventral 
striatum in HD remains unknown. Here, we tested the hypothesis that 
elevated striatal dopamine levels are caused by changes in the substantia 
nigra pars compacta (SNc) and the ventral tegmental area (VTA), since 
these regions are the main source of striatal dopamine (Haber and Fudge, 
1997; Joel and Weiner, 2000). We used antibodies raised against tyrosine 
hydroxylase (TH), the rate-limiting enzyme in the synthesis of dopamine. 
By means of stereological counting methods, we analyzed the number of 
TH containing cells in the SNc and VTA, in the only experimental model 
of HD with chorea, the transgenic rat model of HD (tgHD)(Cao et al., 
2006. Thus far, no other rodent model of HD has shown choreiform 
movements (Cao et al., 2006). This model has recently been created (von 
Horsten et al., 2003), and carries a truncated huntingtin cDNA fragment 
with 51 CAG repeats under control of the native rat Huntington promoter. 
These animals show slowly progressive clinical and pathological 
phenotypes (Cao et al., 2006; Nguyen et al., 2006). In previous work we 
have shown that the clinical symptoms include choreiform movements and 
cognitive and emotional alterations (Cao et al., 2006; Temel et al., 2005) 
and that tgHD rats suffer from a progressive striatal cell loss, striatal 
atrophy and cortical cell damage (Nguyen et al., 2006).  
 
Materials and Methods 
 
Subjects  
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Three groups of male subjects were investigated: homozygous 
transgenic HD (tgHD) rats (n = 5), hemizygous tgHD rats (n = 5), and 
wildtype littermates (n = 4), of approximately 11 months old. After 
genotyping, all rats were transferred from the Friedrich-Alexander-
University Animal Facilities (Erlangen-Nürnberg, Germany) to the Central 
Animal Facilities of Maastricht University (Maastricht, The Netherlands) 
and housed there during the experiments in standard Makrolon™ cages on 
sawdust bedding in an air-conditioned room (about 20 °C). Food, standard 
laboratory chow (Hopefarms, Woerden, The Netherlands), and water were 
available ad libitum. All experimental procedures were approved by the 
Animal Experiments and Ethics Committee of Maastricht University, 
Maastricht, The Netherlands.  
  
Tissue collection 
The subjects were sacrificed after deep anesthesia with Nembutal 
(75mg/kg) and the brains were immediately dissected, followed by 
immersion-fixation with 4% paraformaldehyde in 0.1 M sodium phosphate 
buffer (pH: 7.6). The duration of immersion-fixation was 48 hours, 
followed by overnight immersion in 15% sucrose for cryoprotection. 
Hereafter, selected regions of the brains were cut serially in 30-µm-thick 
coronal sections on a cryostat (MICROM HM 520, Neuss, Germany) and 
stored at -80 °C until processing for TH immunocytochemistry.  
 
Immunocytochemistry  
To evaluate the number of TH containing cells in the SNc and VTA, 
and the level of expression of TH in the dorsal and ventral striatum, we 
processed sections containing the SNc, VTA, and striatum for 
immunocytochemistry. This was carried out using mouse anti-TH (diluted 
1:100, kindly supplied by Dr. C. Cuello, Canada) as primary antibody 
(Temel et al., 2006b). After rinsing steps with Tris-buffered solution and 
Triton X-100, and incubation with the secondary antibody (diluted 1:400 
donkey anti-mouse biotin; Jackson Immunoresearch Laboratories, West 
Grove, USA), the sections were incubated with an avidin-biotin-
peroxidase complex (diluted 1:800, Elite ABC-kit, Vestastatin, 
Hyperdopaminergic status in experimental Huntington’s disease 
 
 
60 
Burlingame, USA). To visualize the horseradish peroxide reaction 
product, the sections were incubated with 3,3′ -diaminobenzidine 
tetrahydrochloride with nickel chloride enhancement.. Finally, the sections 
were mounted and coverslipped using Permount (Fisher Scientific, USA). 
 
Quantitative analysis of TH containing cells in the SNc and VTA 
The immunocytochemically processed sections were used to 
evaluate the total number and volumes of TH immunoreactive (THir) cells 
within the SNc and VTA. All stereological investigations were carried out 
with a stereological computer microscopy system (Stereo Investigator, 
Microbrightfield Bioscience, Williston, USA). In all sections showing the 
SNc and VTA, the region comprising the TH containing cells within the 
SNc and VTA, respectively, was delineated and total numbers of TH 
containing cells and the cell volumes were estimated with the optical 
fractionator and nucleator, respectively (Schmitz and Hof, 2000; Schmitz 
and Hof, 2005; West et al., 1991). More details of the stereological 
counting method has been described before (Temel et al., 2006c). 
 
Quantitative analysis of the TH levels in the dorsal and ventral 
striatum 
The expression levels of TH in the dorsal and ventral striatum 
(nucleus accumbens and olfactory tubercle) were quantified using an 
image analysis system (analySIS Imaging System, Münster, Germany) 
from digital photos taken by an Olympus U-CMAD-2 digital camera 
connected to an Olympus AX 70 microscope (Olympus, Zoeterwoude, the 
Netherlands). Densitometric measurements (Image J software version 
1.38x; NIH, Bethesda, USA) were obtained at two anteroposterior levels 
for the dorsal and one level for the ventral striatum rat, for the right and 
left hemispheres. The coordinates were from bregma for the dorsal 
striatum +0.28 and +1.00, and for the ventral striatum +1.70 (Paxinos and 
Watson, stereotactic atlas of the rat brain, 1998). The data are expressed as 
optical density ratios. 
 
Statistical analysis 
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Data are presented as means and standard errors of means (S.E.M.). 
The quantitative data of the total number of TH containing cells, the 
volumes of the TH containing cells in the SNc and VTA, and the TH 
expression levels in the dorsal and ventral striatum were analyzed using 
one-way ANOVA with a Bonferroni post-hoc multiple comparisons test. 
All statistical analyses were performed with SPSS 15.0 version for 
Windows. P-values less than 0.05 were considered significant.   
 
Results 
 
TH containing cells in the SNc  
Qualitative inspection of the stained sections showed clearly more 
TH containing cells in the SNc of tgHD rats when compared to the 
wildtype littermates (Figure 1). Quantitative analysis revealed that there 
were no significant differences between the right and left SNc in all the 
groups, and therefore the data were pooled.  
 
The mean number of TH containing cells was 9745 in the wildtype 
littermates, 15351 in the hemizygous tgHD rats, and 14180 in the 
homozygous tgHD rats (Figure 2). The number of TH containing cells in 
the hemizygous and homozygous tgHD rats were significantly higher than 
in the wildtype littermates (F= 9.43, P<0.01). There were no significant 
differences between the hemizygous and homozygous animals.  
 
The volumes of the TH containing cells of the right and left SNc 
were not statistically different in all the groups and therefore this data set 
was pooled. The mean volumes of TH containing cells were 2939μm3 in 
the wildtype littermates, 2681μm3 in the hemizygous tgHD rats, and 
3072μm3 in the homozygous tgHD rats. There were no significant 
differences between the groups (Figure 2).   
 
TH containing cells in the VTA  
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Similarly to the SNc, qualitative evaluation of the stained sections showed 
clearly more TH containing cells in the VTA of tgHD rats when compared 
 
Figure 1. Representative low-
power photomicrographs of coronal 
brain sections stained for tyrosine 
hydroxylase (TH) showing the 
substantia nigra pars compacta 
(SNc), medial terminal nucleus of 
the accessory optic tract (aopt) and a 
small part of the ventral tegmental 
area (VTA) of a wildtype littermate 
rat (C), hemizygous transgenic HD 
rat (-/-) and a transgenic HD 
homozygous (+/+) rat. Note the 
increased TH containing cell density 
in the SNc of the hemizygous and 
homozygous transgenic HD rats 
upon close inspection. The high 
power photomicrograph inset in the 
right upper corner shows a 
magnification of a TH containing 
cells of a transgenic homozygous rat. 
The volumes of the TH containing 
cells were not different between the 
groups. Scale bar is approximately 
250μm. The anatomical level is 
approximately anteroposterior -
5.2mm from Bregma according to 
the Paxinos and Watson atlas of 
1998.  
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to the wildtype littermates (Figure 3). Again, quantitative analysis revealed 
no significant differences between the right and left VTA in all the groups, 
and consequently the data were pooled.  
 
 
 
Figure 2. Cumulative data showing the means and SEM’s of the number of TH 
containing cells in the substantia nigra pars compacta (A) and ventral tegmental area (B). 
Note that both the homozygous (+/+) and the hemizygous transgenic HD rats have more 
TH containing neurons than the wildtype littermates (C). A significant difference 
(P<0.05) is indicated by an (*). The cumulative results of the measurements of the 
volumes of the TH containing cells in the SNc and the VTA are shown in figures C and 
D, respectively. There were no significant differences between the groups. 
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The mean number of TH containing cells in the VTA was 3901 in 
the wildtype littermates, 5056 in the hemizygous tgHD rats, and 5726 in 
the homozygous tgHD rats (Figure 2). The number of TH containing cells 
in the tgHD rats was significantly higher as compared to the wildtype 
littermates (F= 9.09, P<0.01). There were no significant differences 
between the hemizygous and homozygous animals.  
 
 
 
The volumes of the TH containing cells of the right and left VTA 
were also not statistically different in all the groups and therefore these 
data were pooled (Figure 1). The mean volumes of TH containing cells 
 
Figure 3. Representative low-
power photomicrographs of coronal brain 
sections stained for TH showing the 
ventral tegmental area (VTA), medial 
terminal nucleus of the accessory optic 
tract (aopt) and the mamillary tubercle 
(MT) of a wildtype littermate rat (C), 
hemizygous transgenic HD rat (-/-) and a 
transgenic HD homozygous (+/+) rat. 
Note the increased TH containing cell 
density in the VTA of the hemizygous 
and homozygous transgenic HD rats upon 
close inspection, while the background 
staining (fiber staining) is comparable. 
The high-power photomicropgraph inset 
in the right upper corner shows a 
magnification of a TH containing cells of 
a transgenic homozygous rat. The 
volumes of the TH containing cells were 
not different between the groups. Scale 
bar is approximately 150μm. The 
anatomical level is approximately 
anteroposterior -5.6mm from Bregma 
according to the Paxinos and Watson 
atlas of 1998.  
aopt 
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were 1546μm3 in the wildtype littermates, 1376μm3 in the hemizygous 
tgHD rats, and 1667μm3 in the homozygous tgHD rats. There were no 
significant differences between the groups. 
 
 
 
 
 
Figure 4. Representative low-
power photomicrographs of coronal 
brain sections stained for TH showing 
the dorsal striatum, and the lateral 
ventricle (LV) of a wildtype littermate 
rat (C), hemizygous transgenic HD rat 
(-/-) and a transgenic HD homozygous 
(+/+) rat. Note the increased TH 
signal in the DS of the hemizygous 
and homozygous transgenic HD rats. 
Scale bar is approximately 1000μm. 
The anatomical level is approximately 
anteroposterior 0.2mm from Bregma 
according to the Paxinos and Watson 
atlas of 1998.  
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TH expression levels in the dorsal and ventral striatum 
Qualitative examination of the TH expression showed again clear 
differences between the tgHD rats and wildtype littermates in both the 
dorsal and ventral striatum (Figures 4 and 5). Quantitative analysis 
revealed no differences between the right and left striatum, and also not 
between the two anteroposterior levels of the dorsal striatum, and therefore 
the data were pooled. 
 
 
 
VS-Ot of the hemizygous and homozygous transgenic HD rats. Scale bar is 
approximately 600μm. The anatomical level is approximately anteroposterior 1.6mm 
from Bregma according to the Paxinos and Watson atlas of 1998. 
 
 
 
Figurer 5. Representative low-
power photomicrographs of coronal 
brain sections stained for TH showing 
the ventral striatum, including the 
nucleus accumbens (VS-NAc) and the 
olfactory tubercle (VS-Ot), part of the 
dorsal striatum (DS) and the anterior 
commissure (AC) of a wildtype 
littermate rat (C), hemizygous transgenic 
HD rat (-/-) and a transgenic HD  
homozygous (+/+) rat. Note the 
increased TH signal in the VS-NAc and  
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Measurements of the optical densities showed that the TH-
expression in the dorsal striatum was significantly higher in the tgHD rats 
as compared to the wildtype littermates (F=8.90, P>0.01). There were no 
differences between the hemizygous and homozygous rats. Similarly, the 
expression of TH in the ventral striatum was significantly higher in the 
tgHD rats than in the wildtype littermates (F=4.56, P>0.05). Again, there 
were no differences between the hemizygous and homozygous rats (Figure 
6). 
 
 
The SNc-dorsal striatum (nigrostriatal) versus the VTA-ventral 
striatum (mesolimbic) dopaminergic system 
Although the dopaminergic efferents from the SNc innervate 
predominantly the dorsomedial striatum, the medial part also innervates 
the ventral striatum (Haber and Fudge, 1997). The dopaminergic efferents 
 
 
Figure 6. Cumulative data showing the means and SEM’s of the level of TH 
expression in the dorsal (A) and ventral striatum (B), measured by calculating the 
optical density ratios. Higher value indicates lower TH expression, and lower values 
indicate more TH expression. Note that the levels of TH expression in both the dorsal 
and ventral striatum are higher in the tgHD animals. A significant difference (P<0.05) 
is indicated by an (*). 
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from the VTA innervate the rest of the ventromedial striatum. To study the 
differences between the groups and the anatomical subregions in more 
detail, we calculated and analyzed the difference scores for all the groups. 
This was performed in order to evaluate whether there was a difference in 
the changes in the VTA-ventral striatum dopaminergic system when 
compared to the SNc-dorsal striatum dopaminergic system. The amount of 
increases in the number of TH containing cells and the level of TH 
expression was similar for both systems. 
 
Increase in cell density  
While semi-quantitative volumetric analysis of the VTA and SNc 
revealed no differences between the groups, we found an obvious increase 
in the density of TH containing neurons in these regions (Figure 7).  
 
 
Discussion 
 
Our results clearly show an increased expression of TH in the 
striatum of tgHD rats. This reflects increased striatal dopamine levels, 
since TH enzymatic activity highly corresponds to the cellular levels of 
dopamine (Yohrling et al., 2003). This is in line with post-mortem human 
studies in the 1980s reporting higher levels of dopamine in HD brains. 
Using a radioenzymatic detection method, Spokes found increased levels 
of dopamine in the striatum (69% increase in the putamen and 32% in the 
caudate nucleus), NAc (87% increase) and the SNc (34%) in post-mortem 
material of 56 HD patients, when compared to control tissue (Spokes, 
1980). While another study with much less subjects, found no changes in 
dopamine levels in post-mortem HD patients (Bernheimer et al., 1973), 
Bird reported increased tyrosine hydroxylase activity in the striatum, NAc 
and substantia nigra (Bird, 1980), supporting the findings of Spokes 
(Spokes, 1980). Higher levels of striatal dopamine were explained by a 
higher density of dopaminergic terminals in the striatum which is undergo- 
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Figure 7. Representative high-power photomicrographs of coronal brain sections 
stained for TH showing the SNc (I-III) and the VTA (IV-VI)  of a wildtype littermate rat 
(C), hemizygous transgenic HD rat (-/-) and a transgenic HD homozygous (+/+) rat. Note 
the increased density of TH containing cells in the hemizygous and homozygous 
transgenic HD rats. Scale bar is approximately 50 μm. 
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-ing shrinkage. However, this could not explain the increase in the NAc 
and the substantia nigra, which do not show clear shrinkage in HD (Bird, 
1980; Spokes, 1980). Indirect evidence for increased striatal dopamine 
levels is also derived from receptor studies. In tgHD rats (Bauer et al., 
2005) and in HD patients (Augood et al., 1997), it has been shown that D1 
and D2 receptors in the striatum are significantly decreased.. 
 
Our findings suggest that the origin of the increased dopamine in the 
striatum comes from the two main nuclei supplying the striatum with 
dopamine, the SNc for the nigrostriatal dopamine pathway and the VTA 
for the mesolimbic dopamine pathway, and is therefore not likely to be 
related to shrinkage of the striatum. Stereological counts of TH containing 
cells revealed a substantial increase in the number of TH containing cells 
in both regions in the tgHD rats when compared to controls. Since it has 
been demonstrated that the total number of cells in the substantia nigra in 
postmortem HD brains were not different from age-matched controls 
(Mann, 1989), it is possible that the increased number of TH containing 
cells in the SNc and VTA is the result of a change in phenotype of the 
non-TH containing cells. For the SNc it is known that about 45% of the 
cells are non-TH containing (Temel et al., 2006c). A change in the 
phenotype of a TH cell, while the cell is still functional, has been 
documented before in the substantia nigra of mice (Aumann et al., 2008) 
and rats (Paul et al., 2004).  
 
There are two popular hypotheses for the consequences of a 
hyperdopaminergic status in HD: chorea induced by increased dopamine 
levels and higher dopamine leading to enhanced neurodegeneration. 
Evidence for the first hypothesis is mainly derived from Parkinson’s 
disease (PD) and clinical observations in HD. In PD, one of the key 
symptoms is hypokinesia, this has been linked to dopaminergic neuron 
loss in the SNc, which can be treated successfully with dopamine-agonists 
and levo-dopa. In line with this, the chorea, which is a hyperkinesia, can 
be treated with dopamine-antagonists and dopamine-depleting drugs. We 
should keep in mind that HD patients can also suffer to, a certain extent, 
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from bradykinesia and rigidity. The second hypothesis, which is mainly 
supported by experimental studies, is that higher concentrations of 
dopamine in the striatum lead to neurotoxicity and therefore plays a role in 
the pathogenesis of HD. Dopamine can auto-oxidize to form dopamine 
quinone, a reactive molecule which spontaneously decomposes to form 
additional reactive species that can induce cell damage (Jakel and 
Maragos, 2000; McLaughlin et al., 1998).  
 
An interesting but provocative opinion is that increased dopamine 
plays a role in chorea, and not so much in neurodegeneration. Findings 
from transgenic mice models of HD support this. For instance in R6/2 
(Ariano et al., 2002; Reynolds et al., 1999) and R6/1 (Petersen et al., 2002) 
mice, lower dopamine levels were found in the striatum, while these mice 
show neurodegeneration but no chorea. In line with this, the tgHD rats as 
demonstrated in this study, show neurodegeneration, but also chorea and 
have a hyperdopaminergic status.     
 
We have not found a difference in the number of TH containing cells 
between the homozygous and hemizygous animals, while differences in 
behavioral performance exist at the age of 11 months (Nguyen et al., 
2006). Interestingly, at this age there is also no difference in the number of 
choreiform movements, which arises at later ages (Cao et al., 2006; Temel 
et al., 2006a). This again supports the opinion expressed in the previous 
paragraph.   
 
In conclusion, in a recently generated transgenic rat model of HD, 
exhibiting progressive neurodegeneration and chorea, we have found 
evidence for increased levels of dopamine in the striatum which is in line 
with post-mortem human studies. Furthermore, our results show that the 
origin of this hyperdopaminergic status lies in an increased number of 
dopaminergic cells in the VTA and SNc, the two main nuclei providing 
the striatum with dopamine.  
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Abstract 
The predominant motor symptom in Huntington’ disease (HD) is 
chorea. The patho-anatomical basis for the chorea is not well known, but a 
link with the dopaminergic system has been suggested by human post-
mortem studies and clinical therapy studies. In a previous study, utilizing 
the transgenic rat model of HD (tgHD), we have shown that this 
hyperdopaminergic status resulted from a substantial increase in the 
number of dopamine containing cells in both the substantia nigra pars 
compacta and ventral tegmental area.  Since we found no clear evidence 
for changes in the total cell numbers in the investigated regions, we 
reasoned that this increase had to be the result of a change in phenotype of 
the non-dopamine containing cells. We decided to study the dorsal raphe 
nucleus, which houses dopaminergic and non-dopaminergic neurons 
which are mainly serotonergic. In tissue containing dorsal raphe nucleus 
obtained from tgHD rats and HD patients, we performed stereological and 
semi-quantitative counting methods, respectively, and analyzed the 
number of dopamine and serotonin containing cells. Our results show that 
the number of dopamine containing cells is substantially increased in the 
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DRN of tgHD rats. Importantly, we have found this hyperdopaminergic 
status also in the DRN tissue of HD patients, establishing a consistency of 
the finding across species. In addition, we found a reduced number of 
serotonin containing cells. Using confocal microscopy and double-staining 
methods, we found no coexpression between dopaminergic and 
serotonergic phenotype in HD. Interestingly, the absolute gain in the 
dopaminergic phenotype was less than the loss of the serotonergic 
phenotype. Our findings suggest that the mutation in HD causes neurons 
to switch phenotypes which may underlie the clinical neurological 
symptoms and provide a novel mechanism for therapy development. 
 
Submitted  
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Introduction  
 
Huntington’s disease (HD) is an autosomal dominantly inherited 
progressive disorder, eventually leading to death (Huntington Study 
Group, 1993; Vonsattel and DiFiglia, 1998). The main symptoms are 
neurological and include motor and non-motor features. The predominant 
motor symptom is chorea, and to a lesser extent hypokinesia. The non-
motor symptoms consist of cognitive dysfunction leading to dementia and 
emotional instability. The chorea can be defined as an abrupt, rapid, brief, 
irregular and unsustained movement. The patho-anatomical basis for the 
chorea is not well known, but a link with the dopaminergic system has 
been suggested by human post-mortem studies and clinical therapy 
studies. Early post-mortem studies showed that striatal dopamine levels, 
both in the dorsal and ventral striatum were significantly higher in HD 
patients compared to controls (Bird, 1980; Bird et al., 1980; Spokes, 
1980). In addition, clinical studies have shown that chorea can be treated 
with dopamine antagonist or dopamine depleting drugs (Mason and 
Barker, 2009). 
 
In a previous study, utilizing the transgenic rat model of HD (tgHD), 
which is one of the few experimental models of HD showing chorea-like 
movements (Cao et al., 2006), we have investigated the origin of elevated 
dopamine levels in the striatum (Jahanshahi et al., 2010). Using antibodies 
raised against tyrosine hydroxylase (TH), the rate-limiting enzyme in the 
synthesis of dopamine, levels of expression of TH in the dorsal and ventral 
parts of the striatum, and the number of TH containing cells in the 
substantia nigra pars compacta (SNc) and the ventral tegmental area 
(VTA) were analyzed. The latter two regions are the main source of the 
nigrostriatal and mesolimbic dopaminergic input to the striatum, 
respectively (Haber and Fudge, 1997; Joel and Weiner, 2000). We found 
increased expression of TH in both the dorsal and ventral striatum of tgHD 
rats, in line with post-mortem clinical studies (Spokes, 1980; Bird, 1980). 
The origin of this increase in striatal TH resulted from a substantial 
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increase in the number of TH containing cells in both the SNc and the 
VTA. Since, we found no clear evidence for changes in the total cell 
numbers in the investigated regions, and since it has been demonstrated 
that the total number of cells in the substantia nigra in postmortem HD 
brains was not different from age-matched controls (Mann, 1989), we 
hypothesized that the increased number of TH containing cells in the SNc 
and VTA had to be the result of a change in phenotype of the non-TH 
containing cells.  
 
Evidence suggests that genetic causes, transcription factors and 
calcium-dependent signaling can determine neuronal phenotype (Marek et 
al., 2010; Velazquez-Ulloa et al., 2011). Whether the development of 
neuronal phenotypes is influenced by the mutation in HD is unknown. 
Here, we tested the hypothesis that the increase in the number of dopamine 
containing cells, as reported earlier (Jahanshahi et al.), is accompanied by 
a decrease of another cell type in the same brain region. We decided to 
study the dorsal raphe nucleus (DRN), which is a prototypical brain region 
housing different types of monoaminergic cell types. The dopamine 
containing cells of the DRN, belonging to the A10 dopaminergic cell 
group, project mainly to the ventral and to a lesser extent to the dorsal 
striatum (Descarries et al., 1986; Stratford and Wirtshafter, 1990) and 
coexist with serotonin containing cells. The latter form the largest group of 
monoaminergic cells within the DRN. We reasoned that the number of 
dopamine containing cells would be increased and the number of serotonin 
containing cells would be decreased. But, we also considered the 
possibility of serotonin containing cells to coexpress the dopaminergic 
phenotype de novo due to the HD mutation (Dulcis and Spitzer), and 
checked for this as well.  
 
In tissue containing DRN obtained from tgHD rats and HD patients, 
we performed stereological and semi-quantitative counting methods, 
respectively, and analyzed the number of dopamine and serotonin 
containing cells. The dopamine containing cells were detected by immuno 
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-histochemical methods with antibodies raised against TH, as reported 
previously (Jahanshahi et al., 2010). Serotonin containing cells were 
identified immunohistochemically with antibodies directed against 
phenylalanine hydroxylase subtype 8 (PH8), which is known to be a 
reliable marker in paraffin-embedded post-mortem human tissue (Haan et 
al., 1987; Tork et al., 1992; Underwood et al., 2007). However, in tissue 
obtained from the tgHD rats, we performed both PH8 and serotonin 
staining to be certain that the staining profiles were identical. We used 
double staining to evaluate the presence of coexpression between the 
dopaminergic and serotonergic phenotype and at the same time checked 
for potential cross-reactivity of PH8 with TH (Haan et al., 1987; Tork et 
al., 1992). 
 
Materials and Methods 
 
We will describe this section in two parts, the animal model and 
post-mortem human tissue work, thereby explaining methods of tissue 
collection, processing and analysis.  
 
Animal model 
Two groups of male rats were investigated: homozygous transgenic 
HD (tgHD) and wildtype littermates (n = 4), approximately 11 months old. 
After genotyping, all rats were transferred from the Friedrich-Alexander-
University Animal Facilities (Erlangen-Nürnberg, Germany) to the Central 
Animal Facilities of Maastricht University (Maastricht, The Netherlands) 
and housed there during the experiments in standard Makrolon™ cages on 
sawdust bedding in an air-conditioned room (about 20 °C). Food, standard 
laboratory chow (Hopefarms, Woerden, The Netherlands), and water were 
available ad libitum. All experimental procedures were approved by the 
Animal Experiments and Ethics Committee of Maastricht University, 
Maastricht, The Netherlands.  
 
 Tissue collection 
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The subjects were sacrificed after deep anesthesia with Nembutal 
(75mg/kg) and the brains were quickly removed, followed by immersion-
fixation with 4% paraformaldehyde in 0.1 M sodium phosphate buffer 
(pH: 7.6). The duration of immersion-fixation was 48 hours, followed by 
overnight immersion in 15% sucrose for cryoprotection. Hereafter, the 
DRN of the brains was cut in 10 series of 30-µm-thick coronal free-
floating sections on a cryostat (MICROM HM 520, Neuss, Germany) and 
stored at -80 °C until processing for immunohistochemistry.  
 
Immunohistochemistry and quantitative analysis 
Tyrosine hydroxylase 
To evaluate the number of TH containing cells, we processed 
sections containing the DRN for immunohistochemistry. This was carried 
out using rabbit anti-TH (diluted 1:1000, Protos Biotech Crop, New York, 
USA) as primary antibody for 24 hours. After rinsing steps with Tris-
buffered solution and Triton X-100, and incubation with the secondary 
antibody (diluted 1:400 donkey anti-rabbit biotin; Jackson 
Immunoresearch Laboratories, West Grove, USA), the sections were 
incubated with an avidin-biotin-peroxidase complex (diluted 1:800, Elite 
ABC-kit, Vestastatin, Burlingame, USA). To visualize the horseradish 
peroxide reaction product, the sections were incubated with 3,3′ -
diaminobenzidine tetrahydrochloride with nickel chloride enhancement. 
Finally, the sections were mounted and coverslipped using Pertex 
(Histolab Products ab, Goteborg, Sweden). 
 
Phenylalanine hydroxylase subtype 8  
To evaluate the number of PH8 containing cells in the DRN, we 
performed an immunohistochemical staining using mouse anti-PH8 
(diluted 1:1000, Santa Cruz Biotechnology Inc, Santa Cruz, USA). 
Incubation in the primary antibody was for three days. The remaining 
steps including the secondary antibody (diluted 1:400, donkey anti-mouse 
biotin; Jackson Immunoresearch Laboratories, West Grove, USA), ABC-
step, and the visualization of the horseradish peroxide reaction product, 
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were similar to the TH staining as described above. The sections were then 
mounted and coverslipped using Pertex. 
 
Serotonin 
In the animal tissue we also performed direct serotonin staining to 
ensure that PH8 was staining serotonergic neurons. Since in the human 
tissue (see below) direct staining of serotonin was impossible and only 
PH8 immunohistochemistry was performed to detect serotonin-containing 
cells. Sections containing the DRN were incubated for three days with a 
rabbit anti-serotonin antibody (diluted 1:50000) (Steinbusch, 1981). The 
staining was completed using the secondary antibody donkey anti-rabbit 
biotin (diluted 1:400, Jackson Immunoresearch Laboratories, West Grove, 
USA), ABC-kit and visualization of the horseradish peroxide reaction 
product. Finally, the sections were mounted and coverslipped using 
Pertex. 
 
Quantitative analysis of TH, PH8 and serotonin containing cells in 
the rat DRN 
The immunohistochemically stained sections were used to evaluate 
the total number and volumes of TH, PH8, and serotonin containing cells 
within the DRN. All stereological investigations were carried out with a 
stereological computer microscopy system (Stereo Investigator, 
Microbrightfield Bioscience, Williston, USA). In all sections containing 
the DRN, the region comprising the TH, PH8, or serotonin containing 
cells, was delineated and total cell numbers and cell volumes were 
estimated with the optical fractionator and nucleator (Schmitz and Hof, 
2000; Schmitz and Hof, 2004; West et al., 1991).  
 
 
Double staining tyrosine hydroxylase and phenylalanine hydroxylase 
subtype 8  
To evaluate the presence of a possible coexpression of TH and PH8, 
we performed an immunofluorescent double-labeling study. Sections 
containing the DRN were incubated with rabbit anti-TH and mouse anti-
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PH8 primary antibodies for 24 hours and three days, respectively. After 
washing steps, brain sections were incubated with the secondary 
anitibodies donkey anti rabbit alexa 594 (1:400, Invitrogen, Breda, the 
Netherlands) and donkey anti mouse Alexa 488 (1:400, Invitrogen, Breda, 
the Netherlands). Sections were then washed, mounted on gelatine coated 
slides and coverslipped with 80% glycerol in TBS.   
 
Confocal microscopy to evaluate coexpression 
To evaluate the presence of possible coexpression of TH and PH8, 
sections containing the DRN double-labeled with TH and PH8 were 
analysed using immunofluorescence spinning disk confocal microscope 
(Olympus DSU BX51WI, Pennsylvania, USA). We used this staining also 
to check for the presence of a potential cross-reactivity between TH and 
PH8 antibodies. We found no evidence for cross-reactivity in tgHD rats 
and wildtype littermates 
 
Human brain tissue 
Tissue Collection 
Brain tissue from 4 Huntington’s disease cases and 4 controls (Table 
1) was obtained from the Neurological Foundation of New Zealand 
Human Brain Bank. The Huntington’s disease cases included 2 males and 
2 females, with a post-mortem interval prior to perfusion between 11 and 
15h. The control cases included 3 males and 1 female with no known 
history of neurological disease, with a post-mortem interval between 17 
and >25h. Brains were perfused as described previously (Waldvogel et al., 
2006), blocks containing the DRN were collected and kept in the same 
fixative for at least 24 h. followed by paraffin embedding. Finally, 8 µm 
sections were cut and processed for immunohistochemistry.  
 
Immunohistochemistry 
Tyrosine hydroxylase 
Human sections on glass slides containing the DRN were first 
deparaffinized by washings steps in xylene and ethanol. The staining 
protocol was similar to the one described for the animal tissue above. The 
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sections were incubated for 48 hours with the primary antibody rabbit anti-
TH (1:1000 dilution, Protos Biotech Crop, New York), and followed by a 
secondary antibody, ABC-step and visualization of the horseradish 
peroxidase complex. Slides were washed, dehydrated and coverslipped 
using Pertex (Histolab Products ab, Goteborg, Sweden). 
 
Phenylalanine hydroxylase subtype 8  
Since direct staining of serotonin in post-mortem paraffin-embedded 
human tissue is very difficult, we performed PH8 imunohistochemistry to 
detect serotonin-containing cells. For this first antigen retrieval was 
performed. Sections were microwaved in 10 mM citrate buffer (pH 6.00) 
for 7 min (650 watt). After 1 min, sections were microwaved for another 5 
min (350 watt).   
 
The slides were incubated with the primary antibody mouse anti-
PH8 (1:1000 dilution, Santa Cruz biotechnolog) for a period of 7 days. 
The following steps were similar to the ones described for the animal 
tissue above.  Finally slides were washed, dehydrated and coverslipped 
using Pertex (Histolab Products ab, Goteborg, Sweden). 
 
Semi-quantitative analysis of TH and PH8 containing cells in the 
human DRN 
We performed a systematic counting of the number of TH and PH8 
containing cells in the human DRN at one anatomical level. We could not 
perform a stereological cell count and reliably measure cell volumes 
because of the limited availability of well-documented post-mortem 
human HD tissue containing the DRN and the fact that the sections were 
cut at 8 µm.  
 
Cell counting was carried out using the same computer-controlled 
microscopy system as used for the stereological quantification of the tissue 
of the rat model (Stereo Investigator, Microbrightfield Bioscience, 
Williston, USA). In all sections showing the DRN, the regions of interest 
were delineated and numbers of cells were counted. 
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Statistical analysis 
Data are presented as means and standard errors of means (S.E.M.). 
The quantitative data of the total number of TH, PH8, and serotonin 
containing cells and the volumes of the cells were analyzed using the 
Independent Samples T-test for both the animal and human work. All 
statistical analyses were performed with SPSS 15.0 version for Windows. 
P-values lower than 0.05 were considered significant.   
 
Results 
 
In line with Materials and Methods section, we will report results in 
two parts with data obtained from our transgenic animal followed by 
human studies.  
 
Animal model 
Dopaminergic phenotype 
Qualitative inspection of the stained sections of the rat DRN showed 
considerably more TH containing cells (Figure 1). The mean number of 
TH containing cells was 2563 in the wildtype littermates and 4622 in the 
homozygous tgHD rats (Figure 2). The number of TH containing cells in 
the homozygous tgHD rats were significantly higher than in wildtype 
littermates (t= -2.66, P<0.05).  
The mean volumes of TH containing cells in the rat DRN were 
1047μm3 in the wildtype littermates and 1662μm3 in the homozygous 
tgHD rats. The mean volumes were significantly higher in the 
homozygous tgHD rats in comparison with the wildtype littermates (t= -
3.72, P<0.01, Figure 2).  
 
Serotonergic phenotype 
Qualitative inspection also revealed a clear-cut change. We found 
fewer serotonin containing cells in DRN sections of the tgHD rats (Figure 
3). Stereological cell counts revealed 25441 PH8 containing cells in the 
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DRN of homozygous tgHD rats and 11150 in the DRN of wildtype 
littermates (Figure 4). 
 
 
 The number of PH8 containing cells was substantially lower in the 
homozygous tgHD rats compared to wildtype littermates (t=6.19, P<0.01). 
The mean volumes of PH8 containing cells in the DRN of homozygous 
tgHD rats was 2922 μm3 and 3579 μm3 in the DRN of wildtype littermates 
(Figure 4). These mean volumes were not significantly different between 
the two groups.  
 
 
 
Figure 1. Representative low-power photomicrographs of coronal brain sections 
stained for tyrosine hydroxylase (TH) showing the dorsal raphe nucleus (DRN) and 
Aqueduct of Sylvius (AQ) of a wildtype littermate rat (left), and a transgenic HD 
homozygous (right) rat. Note the increased TH containing cell density in the DRN of the 
homozygous transgenic HD rats upon close inspection. The high power photomicrograph 
inset in the right upper corner shows a magnification of a TH containing cells of a 
transgenic homozygous rat. Scale bar is approximately 300μm. The anatomical level is 
approximately anteroposterior -8.0 mm from Bregma according to the Paxinos and 
Watson atlas of 1998. 
    AQ 
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In tissue from the rat model, we performed the direct serotonin 
staining. Although, the quality of this staining was less when compared to 
the PH8 staining, probably due to the fact that the rat tissue was not 
perfusion-fixed but immersion-fixed, we found a similar distribution 
pattern, cell count and cell volumes. This means that the PH8 staining 
reliably detects 5-HT containing cells.  
 
 
 
Coexpression between the dopaminergic and serotonergic 
phenotypes 
Using double-labeling fluorescent immunohistochemical stainings 
and confocal microscopy, we evaluated qualitatively the existence of 
coexpression of PH8 and TH in the DRN of both wildtype littermates and 
homozygous tgHD rats. We found no evidence for coexpression of PH8 
and TH (Figure 5). 
 
 
Figure 2. Cumulative data showing the means and SEM’s of the number of TH 
containing cells (A) and of the cell volumes (B), in the rat dorsal raphe nucleus. Note that 
the homozygous (+/+) transgenic HD rats have more TH containing neurons than the 
wildtype littermates and also greater cell volumes. Significant difference (P<0.05) is 
indicated by an (*). 
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Human brain tissue 
Dopaminergic phenotype 
Qualitative inspection of the stained sections of the human DRN 
showed considerably more TH containing cells in the tissue from the HD 
patients (Figure 6). The mean number of TH containing cells was 
significantly higher in DRN of HD patients as compared to controls (t= 
2.58, P<0.05, Figure 7a).  
 
 
 
 
 
 
 
Figure 3. Representative low-power photomicrographs of coronal brain sections 
stained for phenylalanine hydroxylase subtype 8 (PH8), a reliable marker of serotonin 
containing cells, showing the dorsal raphe nucleus (DRN) and Aqueduct of Sylvius (AQ) 
of a wildtype littermate rat (right), and a transgenic HD homozygous (left) rat. Note the 
decreased PH8 containing cell density in the DRN of the homozygous transgenic HD 
rats. The high power photomicrograph inset in the right upper corner shows a 
magnification of a PH8 containing cells of a transgenic homozygous rat. Scale bar is 
approximately 300μm. The anatomical level is approximately anteroposterior -8.0 mm 
from Bregma according to the Paxinos and Watson atlas of 1998.  
    AQ 
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Serotonergic phenotype 
Qualitative inspection of the stained sections of the human DRN 
showed less PH8 containing cells in the tissue from the HD patients 
(Figure 8). The mean number of PH8 containing cells was substantially 
lower in DRN of HD patients than the controls (t= - 2.81, P<0.05, Figure 
7b).  
 
 
 
Discussion 
 
Our results show that the number of TH containing cells is 
substantially increased in the DRN of tgHD rats. These data confirm our 
previously reported hyperdopaminergic status in this animal model of HD 
and extend these findings to a third dopaminergic cell group, besides the 
 
Figure 4. Cumulative data showing the means and SEM’s of the number of PH8 
containing cells (A) and of the cell volumes (B), in the rat dorsal raphe nucleus. Note that 
the homozygous (+/+) transgenic HD rats have less PH8 containing neurons than the 
wildtype littermates, but similar cell volumes. Significant difference (P<0.05) is indicated 
by an (*). 
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previously reported SNc and VTA (Jahanshahi et al., 2010). Importantly, 
we have found this hyperdopaminergic status also in the DRN tissue of 
HD patients, establishing a consistency of the finding across species. The 
consequence of increased number of dopamine containing neurons in the  
 
 
Figure 5. Representative low-power photomicrographs of coronal rat brain 
sections stained for PH8 and TH, and double-stained for PH8 and TH, showing the dorsal 
raphe nucleus (DRN) and Aqueduct of Sylvius (AQ.) of a transgenic HD homozygous 
(+/+) rat. Note that we have not found any coexpression and cross-reactivity of PH8 and 
TH in the investigated cells of the DRN. Scale bar is approximately 100μm. The 
anatomical level is approximately anteroposterior -8.0 mm from Bregma according to the 
Paxinos and Watson atlas of 1998.  
      AQ 
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DRN, which are known to project to both the dorsal and ventral 
striatum like the SNc and VTA, respectively, can be twofold. The first is 
that increased dopaminergic transmission in the striatum leads to 
hyperkinesias, so potentially to chorea. This hypothesis is supported by 
clinical data showing that the chorea can be treated with dopamine-
antagonists and dopamine-depleting drugs and that dopaminergic 
replacement therapy in Parkinson’s disease patients leads to dyskinesias. 
The second consequence can be that higher concentrations of dopamine in 
the striatum lead to neurotoxicity and therefore plays a role in the 
pathogenesis of HD. Dopamine can auto-oxidize to form dopamine 
quinone, a reactive molecule which spontaneously decomposes to form 
additional reactive species that can induce cell damage (Jakel and 
Maragos, 2000; McLaughlin et al., 1998).  
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We found an increased cell volume of TH containing cells in the 
DRN of tgHD rats. Generally, an increase in cell volume reflects either 
early stages of cell damage (cell swelling) or increased cell activity related 
hypertrophy. The latter would fit with the hypothesis of an increased 
dopaminergic output from the DRN towards the striatum. However,  in our 
previous study examining the TH containing cells in the SNc and VTA, 
we found no increased cell volumes (Jahanshahi et al., 2010). Therefore, 
the relevance of this finding is unclear. 
 
 
Figure 6. We performed a systematic counting of the number of cells in the human 
DRN at one anatomical level. This level is shown here with representative low-power 
photomicrographs of an axial brain section of half of the brainstem stained for Nissl (A) 
of a  control patient (scale bar is approximately 4.2 mm),  including the dorsal raphe 
nucleus (DRN), Aqueduct of Sylvius (AQ), and substantia nigra (SN). In addition, we 
show representative low-power photomicrographs of axial brain sections stained for TH 
of a control (C, scale bar is approximately 0.5mm), and a HD specimen. In the HD 
specimen, only a small part of the AQ is shown in the right upper corner. Note the 
increased TH containing cell density in the DRN in the HD specimen. The high power 
photomicrograph inset in the left corner of the HD tissue shows a magnification of a TH 
containing cells from the DRN of the HD specimen. 
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Our results suggest that the increase in the number of dopaminergic 
cells in HD comes from a change in cell phenotype. We found in the DRN 
of tgHD rats and human post-mortem HD tissue, a reduced number of 
serotonergic and increased number of dopaminergic cells, in comparison 
to controls. Serotonin and dopamine containing cells coexist in the DRN 
and show no coexpression under physiological conditions. Using confocal 
 
Figure 7. Cumulative data showing the means and SEM’s of the number of TH 
containing cells (A) and the number of PH8 containing cells, in the dorsal raphe nucleus 
of controls and HD patients. Note that the DRN of the HD patients has more TH 
containing neurons and less PH8 containing neurons than the wildtype littermates. 
Significant difference (P<0.05) is indicated by an (*). 
 
 
 
Figure 8. Representative low-power photomicrographs of axial brain sections stained for 
PH8 showing the half of the human dorsal raphe nucleus (DRN) and Aqueduct of Sylvius 
(AQ) of a control (C), and a HD specimen. Note the decreased PH8 containing cell 
density in the DRN in the HD specimen upon close inspection. The high power 
photomicrograph inset in the right upper corner shows a magnification of a PH8 
containing cells from the DRN of the control specimen. Scale bar is approximately 
0.5mm. The anatomical level is similar to the Nissl stained section shown in Figure 6. 
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microscopy and double-staining methods, we found no coexpression 
between dopaminergic and serotonergic phenotype in HD and control 
tissue. Interestingly, the absolute gain in the dopaminergic phenotype 
seems to be less than the loss of the serotonergic phenotype. This suggests 
that there is additional cell loss in serotonin containing cells in the DRN of 
tgHD animals. Since, the serotonin containing cells form the majority of 
the cells of the DRN (circa 60%) (Fu et al., 2010), a substantial loss in this 
cell type should be obvious (Steinbusch, 1981). In a small study, we have 
quantitatively assessed the total number of cells in the DRN of tgHD rats 
and wildtype littermates using a Nissl staining. The total numbers were 
similar, approximately 40 000 cells in both. This means there is no actual 
loss of cells in the DRN of tgHD rats. A provocative explanation can be 
that serotonin-containing cells are switching their phenotype not only to 
become dopamine-containing cells, but also to become another type of 
cell. This opens a new window for future investigation. Another 
explanation, which however seems unlikely, is the HD mutation may 
change the detection level of serotonin.  
 
How can cells switch to the dopaminergic phenotype? There are 
generally two possible mechanisms: either a cell changes its phenotype 
entirely to a different phenotype, or a cell maintains its original phenotype 
but starts to coexpress de novo an unusual phenotype. Thus far, we have 
evidence for the first mechanism, but cannot rule out the second. 
Generally, dopaminergic neurons are a heterogeneous population 
expressing additional neurotransmitters such as GABA and/or 
neuropeptide Y (Velazquez-Ulloa et al., 2011). Using experimental 
models, several factors have been identified in the development of the 
dopaminergic phenotype such as Pax6 (Vitalis et al., 2000), Lim1,2 
(Moreno et al., 2004), Nurr1 (Jankovic et al., 2005), and calcium spike 
activity (Velazquez-Ulloa et al., 2011). Calcium spike activity in turn 
controls the expression of the some of these factors. In recent studies 
transforming fibroblasts into dopaminergic neurons, the transcription 
factors Mash1, Lmx1a, FoxA2and Nurr 1 have been found to be critical 
(Caiazzo et al.; Pfisterer et al.). In experimental models or cell lines of 
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HD, evidence has been found for altered Ca
2+
 signaling, but this has been 
classically linked to striatal cell damage mechanisms (Bezprozvanny and 
Hayden, 2004; Tang et al., 2005; Zhang et al., 2008). It is possible that HD 
causes a change in the activity of one or more of these transcription factors 
encoding for dopaminergic neurotransmitter specification by a mechanism 
still to be unraveled. 
 
Conclusion 
 
In the transgenic rat model of HD and in postmortem human HD 
tissue, we found increased number of dopamine containing neurons and 
decreased number of serotonin neurons in the DRN. These findings 
suggest that the mutation in HD causes neurons to switch phenotypes 
which may underlie the clinical neurological symptoms and provide a 
novel mechanism for therapy development. 
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Abstract 
 
Although many studies have appeared on the mechanisms of 
neurogenesis in the adult mammalian central nervous system, the 
challenge remains to identify the factors controlling this process. Among 
numerous factors, which have been described to influence neurogenesis, 
serotonin (5-hydroxytryptamine, 5-HT) has received considerable 
attention. 5-HT drug manipulations and their effects on neurogenesis have 
revealed that 5-HT contributes to adult neurogenesis. An interesting but 
relatively unexplored attribute is the presence of an extensive plexus of 5-
HT containing fibers in the subventricular zone, one of two main 
neurogenic brain structures. A dense layer of 5-HT fibers overlaps the 
subventricular zone, separating this region from the adjacent structures of 
the lateral ventricle. This close anatomical relationship suggests an 
important functional role for 5-HT in influencing cell proliferation in the 
subventricular zone. Here, we review the literature and propose that 
subependymal plexus is part of an intrinsic brain mechanism which 
controls the subventricular zone cell proliferative capacity by modulating 
5-HT release.  
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Introduction 
 
Neurogenesis is the process of generating new neurons from 
populations of stem and progenitor cells. Stem cells reside in distinct areas 
of the brain, and after the proliferation stage, their progeny migrate to 
target regions and eventually differentiate into specific neuronal cell types. 
Ultimately, these newly formed neuronal cells are incorporated into 
existing neuronal cell populations, and integrate into mature neuronal 
circuits (Alvarez-Buylla et al., 2001; Temple, 2001). For decades it was 
believed that only gliogenesis took place under certain conditions and 
generation of new neurons seemed to be unlikely in adult brain. However, 
the discovery of the method of labeling dividing cells with tritiated 
thymidine (Sidman et al., 1959) and few decades later with 5-
bromodihydroxyuridin (BrdU) provided new ways to trace dividing cells 
in the central nervous system (CNS) and presented evidence that neurons 
are continuously generated in the adult mammalian brain (Luskin, 1993). 
Neurogenesis plays a crucial role in the maintenance of brain functioning 
and is more and more targeted in the search for novel therapies for 
neurodegenerative diseases, like Parkinson’s and Alzheimer’s disease, and 
diseases with profound cell loss such as stroke or brain contusion 
(Abdipranoto et al., 2008; Arvidsson et al., 2002).  
 
Neurogenesis occurs mainly at two sites in the mammalian brain, in 
the dorsolateral walls of the lateral ventricles, known as the subventricular 
zone (SVZ), and in the subgranular zone (SGZ) of the dentate gyrus (DG) 
of the hippocampal formation (Luskin 1993; Eriksson, 2007; van Praag et 
al., 2002). Interestingly, neurogenesis has been reported to be a more 
widespread phenomenon with progenitor cells giving rise to new neurons 
in other adult brain regions such as the CA1 area of the hippocampus 
(Rietze et al., 2000), amygdala (Bernier et al., 2002), substantia nigra 
(Zhao et al., 2008) hypothalamus (Kokoeva et al., 2005), third ventricle, 
and neocortex (Gould et al., 1999;; Xu et al., 2005; Zhao et al., 2003) for 
review see also Migau et al. (2010). Although, it has been suggested that 
in certain conditions such as stroke, ischemia or exposure to growth  
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factors, these apparently “dormant” progenitor cells may become activated 
and form new neuronal cells (Darsalia et al., 2005; Lichtenwalner and 
Parent, 2006), there is only few direct evidence showing the activation of 
neurnal progenitors out of adult germinal regions in pathological situation 
(Ohira et al., 2010). The functional significance of these multi-site 
phenomena are under debate. In this review, we will focus on the SVZ.  
 
Many studies have appeared on the mechanism of the formation of 
new cells in the SVZ. However, the challenge remains to identify the 
factors controlling this process. In this respect, an interesting but relatively 
unexplored factor is the presence of 5-hydroxytryptamine (5-HT, 
serotonin). As demonstrated in Figure 1, the SVZ is densely innervated 
with 5-HT containing fibers. Therefore, this region is referred as the 
subependymal 5-HT complex. These 5-HT fibers originate from the dorsal 
raphe nucleus (DRN) and the median raphe nucleus (MNR) (Figure 2). In 
line with this, high levels of 5-HT have been measured in the SVZ (Chan-
Palay, 1976) and while 5-HT fibers are present along all ventricles, the 
highest densities have been found along the lateral ventricles neighboring 
the SVZ (Steinbusch, 1981). This close anatomical relationship predicts an 
important functional role for 5-HT to influence cell proliferation in the 
SVZ. Interestingly, lesioning the dorsal raphe nucleus 5-HT system using 
specific neurotoxin against 5-HT neurons reduces the proliferation of 
progenitor cells in the SVZ. These suggest a direct controlling role for 5-
HT from the subependymal 5-HT fibers on neurogenesis in this germinal 
region (Brezun and Daszuta, 1999). In addition, 5-HT has a direct effect 
on the survival of SVZ derived neuronal stem cells in vitro (Hitoshi et al., 
2007). This hypothesis is indirectly supported by the results of 
pharmacological studies. Selective serotonin reuptake inhibitors (SSRIs) 
and other 5-HT active drugs, given to enhance central 5-HT levels, can 
induce neurogenesis in animal models (Nandam et al., 2007; Newton and 
Duman, 2007; Banasr and Duman, 2007). While these are extrinsic 
enhancers of 5-HT function, we hypothesize that the subependymal plexus 
is the brain’s intrinsic 5-HT mechanism to control SVZ’s cell proliferation 
capacity. While 5-HT drug manipulations and their effects on neurogenes- 
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Figure 1. Representative photomicrographs of coronal sections of the rat brain 
showing the subventricular zone (SVZ) stained for Ki-67 (A and C), a widely used 
marker for cell proliferation, and 5-hydroxytryptamine (B and D). Figures A and B are 
low-power and figures C and D are high power photomicrographs. Figures C and D show 
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the delineated areas in figures A and B, respectively, in detail. Note the dense 5-HT 
containing fiber network around the proliferating cells in the SVZ. Other surrounding 
anatomical structures are corpus callosum (CC) and lateral ventricle (LV).  
 
-is have received much attention, the interaction between subependymal 5-
HT innervation and the SVZ has received little attention. Here, we review 
the latter interaction in detail.   
 
The neuroanatomy of the subependymal 5-HT plexus 
 
The brainstem DRN and MRN, cell groups B7 and B8, respectively 
according to Dahlstrom and Fuxe (1964), are the main source of forebrain 
5-HT innervation (Michelsen et al., 2007 and 2008; Steinbusch et al., 1980 
and 1981; Steinbusch, 1981). The SVZ forms a complex of cells 
topographically organized with respect to the lateral ventricles (Mikkelsen 
et al., 1997; Simpson et al., 1998; Aghajanian and Gallager, 1975; 
O'Hearn and Molliver, 1984). There is a fine network of varicose axons 
underneath the ependymal layer. Many of these fibers extend into the 
ependyma forming a plexus within the ventricular wall (Moore and Speh, 
2004; Richards and Tranzer, 1974). During evolution mammals have lost 
their CSF-containing 5-HT cells in the ependymal wall. However, these 5-
HT cells have been replaced in mammals by the prominent 5-HT fiber and 
buttons complex along the ventricular wall (Smeets and Reiner, 1994; 
Steinbusch and Nieuwenhuys, 1983). The development of the 5-HT 
complex along the lateral ventricles takes place in first two weeks after 
birth. During this period, fibers become thinner, longer, expressing a high 
number of varicosities and get intermingled to form a dense plexus 
(Dinopoulos and Dori, 1995; Lidov and Molliver, 1982). This 5-HT plexus 
in primates is reported less dense in comparison to rodents (Richards and 
Tranzer, 1974). Interestingly, some of the 5-HT projections to the SVZ 
have a band-like pattern of innervation, which is different from the pattern 
of 5-HT projections to the neighboring striatum (Simpson et al., 1998). 
This pattern is thought to play an important role in creating a highly 
localized microenvironment, the so called niche (Hagg, 2005) (Figure 3).  
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The SVZ 5-HT complex is a unique structure, but its exact functional 
significance still remains unclear. Naturally, some hypotheses exist. 
Besides its involvement in neurogenesis, its relation to the cerebro-spinal 
fluid (CSF) system is of interest. Varicosities of 5-HT fibers innervating 
the SVZ appear to regulate variety of ependymal activities. Secreted 5-HT 
from the fibers has been shown to increase intracellular metabolism in the 
ependymal epithelium (Prothmann et al., 2001) and in turn increases the 
frequency of ciliary beats (Nguyen et al., 2001). Ependymal cells have 
been observed to facilitate the “sink” action of CSF by removing various 
numbers of molecules including 5-HT when CSF passes through the 
parenchymal extracellular space into the ventricles (Verleysdonk et al., 
2004).  
 
 
 
Specific reuptake capacity of extracellular 5-HT has also been 
suggested for astrocytes in the SVZ (Del Bigio, 1995; Verleysdonk et al., 
2004). Early observations showed that 5-HT fibers penetrate the 
ependymal layer to form a so-called supraependymal complex (Chan 
 
Figure 2. Representative 
photomicrographs of frontal sections of 
the rat brain stained for tryptophan 
hydroxylase (TPH), the rate limiting 
enzyme in 5-hydroxytryptamine (5-HT, 
serotonin) production, showing the TPH 
containing in the dorsal raphe (DRN) and 
median raphe (MRN) nuclei. 
Close communication between the subependymal... 
 
 
106 
Palay, 1976; Matsuura et al., 1985; Sano et al., 1982; Richards et al., 
1973), but in later studies this was not confirmed (Dinopoulos and Dori, 
1995).  
 
Whether the 5-HT fibers in SVZ make classical synaptic and/or 
synaptic contacts with stem cells, transit amplifying cells (type C) or with 
neuroblasts (type A), remains to be determined. An alternative route for 
the action of 5-HT can be diffusion. It has been shown that 5-HT released 
at varicosities and exocytotic release sites can be transported by diffusion 
to sites of action (Cloft and Mitchell, 1997; Descarries et al., 1975). 
 
 
 
Figure 3. Low-power 
photomicrographs of rat 
coronal sections containing 
the subventricular zone 
(SVZ) stained for 5-HT. 
Figures show the presence 
of highly localized band like 
pattern of 5-HT containing 
fibers (dashed lines) 
aligning the SVZ. 
 
 
Neuronal proliferation in the SVZ 
 
Neuronal stem cells are primitive cells with multipotent properties 
possessing proliferation (self-renewal) and differentiation abilities to 
generate neuronal and non-neuronal cells in the central nervous system. 
Stem cells have been described to have the capacity to divide indefinitely. 
Due to the self-renewal ability of stem cells, they give rise to several 
orders of progeny magnitude and appear to be able to generate three main 
cell types including: neurons, astrocytes, and oligodendrocytes (Reynolds 
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and Rietze, 2005). Progenitor cells are the intermediate daughter cells with 
limited capacity of self-renewal and proliferative characteristics and due to 
restricted properties, these cells can only give rise to a more limited 
variety of cell types (Bull and Bartlett, 2005; Seaberg and van der Kooy, 
2002). Stem and progenitor cells in the SVZ consist of three major types 
(Doetsch et al., 1997) (Fig. 4). Type “A” cells are known as migratory 
neuroblasts which are mainly targeting the olfactory bulb. Type B cells are 
generally glial fibrilary acidic protein (GFAP) positive astrocytes, 
surrounding the migration channels. Type “B” cells which surround the 
migration channels resemble the ultrastructural morphology of astrocytes 
and generally express GFAP. Along this migration  channel, young type A 
neuroblasts migrate rostrally in a chain shape pattern towards the rostral 
migratory stream (RMS) and from there continue towards the olfactory 
bulb (OB). Type B cells are self-renewing multipotent precursors of newly 
formed neurons. They are in fact regional neural stem cells that give rise 
to type C cells, which in turn develop into migratory type : A” neuroblasts 
(Taupin 2006; Lovell-Badge, 2001; Doetsch et al., 1999). According to 
Doetsch and Hen, (2005), the adult SVZ contains the highest number of 
stem and progenitor cells. 
 
Type A neuroblasts gives rise to neurons by new immature neurons, 
the so-called neuroblasts. They migrate from the SVZ through the RMS 
till the OB as mentioned as “tangential migration” and then migrate 
radially to the most external OB layers including not only the glomerular 
layer (periglomerular cells), but also the granule cell layer, which accounts 
for the large majority of SVZ newborn neurons. These cells become 
integrated within the neuronal circuitry of the OB and become for instance 
interneurons expressing the inhibitory transmitter γ-aminobutyric acid 
(GABA) and/or the modulatory transmitter dopamine (Lledo et al., 2006 
and 2008; Menezes et al., 1995). The ultrastructural architecture of the 
adult rodent RMS has been well described by Whitman and Greer, (2009). 
However the RMS appears not to be the only route for migration. 
Migration of progenitors into the overlying white matter and cortex and 
striatum has been reported in rodents as well (Zerlin et al., 1995). 
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Moreover, studies have demonstrated migration of newly generated 
neurons from SVZ to the substantia nigra in mice (Zhao et al., 2003), and 
frontal cortex in macaque monkeys (Gould et al., 1999). Additionally, 
neuroblasts have been shown to migrate from the SVZ to the amygdala in 
the rabbit (Luzzati et al., 2003). In humans, the exact location of the neural 
stem cells is yet to be determined. However, the presence of stem cells has 
only been reported in the wall of the anterior horn and body of the lateral 
ventricles (Quinones-Hinojosa et al., 2006). Although, the migration of 
neuroblasts from SVZ to olfactory bulb has been reported in the human 
brain (Eriksson, 2007), in adult primates it is still debated whether the 
rostral migration of neuroblasts really exists (Curtis et al., 2007). 
Moreover, migratory neuroblasts in rodents form chains of migratory cells 
toward the OB and in primates they migrate more or less individually 
(Quinones-Hinojosa et al., 2006). It is important to note that under 
physiological conditions, SVZ cells in all mammals so far investigated 
(with few exceptions, i.e., humans) are fated to become exclusively OB 
interneurons. 
 
An interesting but provocative opinion is that stem cells in SVZ 
underlie neurogenesis in DG, the other main neurogenic region of the 
adult brain. As evidence multipotent stem cells have been isolated from 
the subventricular zone of the posterior periventricular area (pLV) near the 
vicinity of the hippocampus. Experimental data have demonstrated that 
these stem cells in the pLV divide and give rise to neuroblasts that migrate 
over a very short distance from the SVZ into the SGZ neurogenic site 
(Bull and Bartlett 2005; Doetsch et al., 1999; Seaberg et al., 2002). 
Moreover, tracing of the caudal SVZ neuronal stem cells has demonstrated 
that they reach the CA1 region of the hippocampus, and differentiate into 
pyramidal neurons (Nakatomi et al., 2002). 
 
5-HT and neuronal proliferation in the SVZ  
 
The role of 5-HT in the development and regulation of adult 
neurogenesis has generally received more attention than other 
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monoamines (Djavadian, 2004; Gaspar et al., 2003). 5-HT 
neurotransmission appears to be among one of the earliest to be developed 
in the fetal brain (Djavadian, 2004; Lauder and Krebs, 1978; Vaidya et al., 
2007) and has been described as a phylogenetically ancient 
neurotransmitter (Azmitia, 2001). 5-HT plays an essential role in the 
vertebrate brain development. It regulates its shape and patterns of 
neuronal connectivity (Lauder, 1990; Wesemann, 1978; Whitaker-Azmitia 
et al., 1996). 5-HT is also known to induce synaptogenesis (Lipton and 
Kater, 1989), electrogenesis (Lessmann and Dietzel, 1991) and neurite 
outgrowth (Lieske et al., 1999; Mercer et al., 1996). It also plays a pivotal 
relevant role in the survival of neuronal circuits and synapses in the adult 
brain (Moriizumi et al., 1994; Okado et al., 1993).  
 
 
 
Figure 4. A schematic representation of the microstructure of the subventricular zone 
(SVZ); (a) the anatomical position of the SVZ from a coronal view. (b), a higher 
magnitude schematic view is given of the stem/progenitor cells, 5-hydroxytrytamine 
fibers and ependymal cells in the SVZ. (c), a detailed schematic overview is given of the 
relationship between the type ‘‘A’’ migratory neuroblasts (A), type ‘‘B’’ neuronal stem 
cell (B), type ‘‘C’’ neuronal progenitor cell (C), ependymal cell (E), lateral ventricle 
(LV) and 5- hydroxytryptamine fibers (5-HT), (CC) corpus callosum’’. 
 
a b c 
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Lesion studies have shown that lesioning the raphe 5-HT neurons 
reduces the number of cells in the SVZ, suggesting a direct controlling 
role for 5-HT from the subependymal 5-HT fibers (Brezun and Daszuta, 
1999). In a recent study, increase in proliferation of SVZ derived cells was 
found by administration of 5-HT (Cheng et al 2010). Interestingly, higher 
concentrations of 5-HT reduced the proliferative capacity, suggesting a 
potential fine-tuning effect for 5-HT. The influence of 5-HT on 
proliferation of cells has also been reported in in vivo studies (Lauder and 
Krebs, 1978, Gaspar et al., 2003). 
 
Although the expression of functional 5-HT receptors in the SVZ 
cells is not entirely known yet, data from in vivo experiments using 5-HT 
receptor agonists and antagonists have shown the neurogenic effects to be 
(partly) mediated by the 5-HT1A and 5-HT2C receptors. Activation of the 
5-HT1A and 5-HT2C receptors in the choroid plexus by systemic 
administration of agonists, 8-OH-DPAT (8-hydroxy-2-N-propylamino) 
tetralin and RO600175 respectively, caused a 50% increase in cell 
proliferation in the rat SVZ (Banasr et al., 2004; Soumier et al., 2010). It 
has been shown that activation of 5-HT receptors in the choroid plexus, 
including the 5-HT2C receptor, by agonists or direct infusion of 5-HT into 
the ventricles, stimulates the secretion of growth factors such as FGF-2 
(Hitoshi et al., 2007). These neurotrophins can enhance the proliferation in 
the SVZ. The notion that 5-HT2C receptors have distinct functional 
properties of inverse agonistic activity (Barker et al., 1994), may explain 
the observations concerning the fine-tuning effect of 5-HT on neuronal 
proliferation in the SVZ. This perhaps happens due to constitutive activity 
of the 5-HT2C receptors in the choroid plexus by ambient 5-HT released 
from serotonergic terminals in the SVZ into the CSF. The 5-HT1B 
antagonist GR127935 also enhanced SVZ cell proliferation, while the 5-
HT1B agonist sumatriptan exerted the opposite effect. In addition, 
systemic administration of the 5-HT2A agonist DOI (2,5-dimethoxy-4-
iodophenyl-2-aminopropane) increased cell proliferation in the SVZ 
(Banasr et al., 2004), the same was the case for buspirone, a 5HT1A 
receptor partial agonist (Grabiec et al., 2009). 
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Selective serotonin reuptake inhibitors (SSRI), which are widely 
used to treat mood disorders, have been shown to enhance cell 
proliferation in animal models (Lau et al., 2007). Interestingly, atypical 
neuroleptics such as haloperidol, paliperidon and risperidone, which have 
the potential the block some 5-HT receptors, have the capacity to increase 
cell proliferation in the SVZ as well (Green et al., 2006; Nasrallah et al., 
2010; Wakade et al., 2002). This makes the situation on the effect of 5-HT 
receptors rather complicated. In addition to experimental studies, in 
schizophrenic patients treated with olanzapine enhancement of cell 
proliferation was found in the forebrain (Lieberman et al., 2005). 
 
Conclusion 
 
The presence of a dense 5-HT fiber complex in the vicinity of the 
stem cells of the SVZ is an intriguing anatomical fact. This close 
anatomical relationship suggests an important functional role for 5-HT in 
influencing cell proliferation in the SVZ. It remains unsolved how 5-HT 
released by terminals in the subependymal complex reaches the cells in the 
SVZ. There are two possibilities: direct synaptic contact and diffusion. 
Synaptic contact has not been found, but we have to bear in mind that it 
has not been investigated in detail yet. Diffusion of 5-HT to the 
neighboring stem cells is a plausible mechanism. It might well be that both 
mechanism exist and are activated depending on the action required. In 
this respect, evidence suggest a fine-tuning effect of 5-HT on cell 
proliferation, enhanced by lower concentrations and decreased by higher 
levels.  
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In vivo brain repair? 
 Electrical fields attract newborn brain cells. 
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Abstract 
The subventricular zone contains stem cells of the brain. After 
proliferation, these cells normally migrate towards different brain regions. 
Here, we report the discovery of a novel approach directing this migration. 
Epidurally applied electrical fields attracted newborn brain cells to the 
adult rat neocortex where they expressed neuronal marker. Interestingly, 
this process was accompanied by enhanced proliferation by a serotonin 
dependent mechanism.  
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Stem cells are present at specific sites in the mammalian brain, including 
the subventricular zone (SVZ) (Arvidsson et al., 2002). The SVZ contains 
the highest number of stem and progenitor cells (Doetsch and Alvarez-
Buylla, 1996). After proliferation in the SVZ, newborn cells migrate 
rostrally mainly towards the olfactory bulb (OB) (Curtis et al., 2007). 
Most of them become glia and small part neurons (Doetsch and Alvarez-
Buylla, 1996). Although specific factors influencing the rate of 
proliferation have been identified (Palmer et al., 1999), tools controlling 
the direction of migration of newborn cells are not available. Here, we 
report the discovery of a novel approach, namely, the epidural application 
of specific electrical fields to direct migration of newborn brain cells to the 
area of interest utilizing animal models. At the same time, we observed 
enhanced proliferation and increased differentiation into the neuronal cell 
phenotype. 
 
We performed a set of experiments motivated by recent studies showing 
neurotrophic effects of high frequency electrical stimulation of the brain 
(Stone et al., 2011; Toda et al., 2008), and electrical fields (EFs) inducing 
movement of different cell types in vitro (Li et al., 2008; McCaig et al., 
2005; Mycielska and Djamgoz, 2004).   
 
First, we established a tool to apply EFs. We designed and manufactured 
an electrode with 2 rows with each 3 contacts for epidural placement 
above the rat sensorimotor cortex (supplementary material and Fig. 1H). 
The second step was the determination of stimulation parameters. We 
developed a theoretical framework to establish specific EFs. We applied 
cathodic current based on in vitro observations that stem and progenitor 
cells show mobility responses to cathodic stimulation instead of anodic (Li 
et al., 2008). In addition, we used a monopolar setting to reduce the risk of 
tissue damage (Temel et al., 2004). The stimulation frequencies were low 
(30 Hz) (Jeong et al., 2009; Nguyen et al., 1999; Tsubokawa et al., 1993) 
or high (330 Hz) (Salimi et al., 2008), based on findings on cell mobility 
and regenerative processes, respectively. We applied low amplitude 
current, approximately 80 µA/contact, in the range, which is observed in 
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physiological conditions in neuronal networks in vivo (Borgens and Shi, 
1995).  
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Figure 1. Representative photomicrographs of coronal brain sections showing the 
proliferating (Ki-67 containing) cells in the SVZ in an animal with sham treatment (A), 
low frequency EFs (B), and high frequency EFs (C). The scale bar is 400µm. A high 
power photomicrograph of one cell is shown in the inset in (C), scale bar = 5µm. Note the 
presence of more cells in the SVZ in the animals with EFs. cc= corpus callosum, LV= 
lateral ventricle. (D) Shows the cumulative data of the Ki-67 and * indicates a statistically 
significant difference in comparison to sham treatment. 
(E) Graph shows the cumulative data for the BrdU cell counts. Note that in animals with 
the application of EFs, more new born cells were found in the cortex below the electrode. 
Interestingly, these cells expressed more often the neuronal marker NeuN in the 
stimulated animals (F). Figure G shows photomicrographs of such a newborn neuron 
migrated towards the EFs in more detail. This cell is contains both BrdU and NeuN. In 
G1 (x-view, scale bar = 10µm.), G2 (y-view, scale bar = 10µm) and G3 (z-view, scale bar 
= 10µm), we show a 3-D reconstruction of such cell and in G4 (scale bar = 20µm), G5, 
and G6 shows the evidence for double-labeling of NeuN and BrdU in the same cell.      
(H) Figures illustrate the electrode construction designed and manufactured by us. It 
consists of one central rectangular part for the connection of a wire and 6 round electrode 
contacts. H1 shows the view from the top and H2 from the bottom.  
 
 
Third, we applied these EFs epidurally to the right sensorimotor cortex of 
rats after implanting the electrodes using microsurgical techniques 
(supplementary material). In a behavioral analysis task, we observed no 
motor responses with currents of mentioned above. Higher currents (> 
150µA/contact) clearly induced contralateral limb movements. Subjects 
were rats and were divided into the following three groups: high frequency 
EFs, low frequency EFs, and controls receiving sham treatment. All 
animals were connected to the stimulators for approximately 4 hours per 
day, and only animals of the high frequency and low frequency groups 
received stimulation. We found no effects of these EFs on the general 
well-being and physiological behavior of the subjects. The animals were 
treated for 31 days.  
 
Fourth, we evaluated the influence of epidurally applied EFs on 
proliferation, migration and differentiation.  
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Figure 2.  (A). Graph shows the cumulative data for the BrdU cell counts in the olfactory 
bulb.  Note that in animals with the application of EFs, more new born cells were found 
in the cortex below the electrode.  
(B). Proliferating (Ki-67 containing) cells are in close contact with 5-HT containing 
fibers in the SVZ as demonstrated here by a double-labeling study, scale bar 30µm. In 
animals with epidurally applied EFs (D, this is a rat from the HF group), fibers showed 
more 5-HT when compared to controls (C), scale bar = 400 µm. The inset in C shows a 
high power photomicropgraph of a 5-HT containing fiber, scale bar 10µm. cc= corpus 
callosum, LV= lateral ventricle. (E) Shows the cumulative data of the optical density 
measurements of 5-HT containing fibers in the SVZ and * indicates a significant 
difference. 
(F) Photomicrographs of an activated (c-Fos) 5-HT containing cell in the DRN in three 
dimensions (F1, z-axis; F2, y-axis, F3, z-axis), scale bar 10µm.  F4 (scale bar = 25µm), 
F5 and F6 photomicrographs show the evidence for double-labeling of c-Fos with 5-HT 
in the same cell. In graph (G), the cumulative data on the number of c-Fos containing 
cells in the DRN are shown.      
 
 
We injected all animals with thymidine analog 5bromo-2deoxyuridine 
(BrdU) five days before stimulation started (supplementary material). 
After the last stimulation session, we sacrificed all animals, removed their 
brains and processed them for further analysis.  
 
Analysis of proliferation in the SVZ was performed by determining the 
number of dividing cells using Ki-67 immunocytochemistry, a marker of 
proliferating cells (supplementary material) (Scholzen and Gerdes, 2000). 
In animals with epidurally applied EFs, we found a striking increase in the 
number of proliferating cells in the ipsilateral SVZ (F=17.845, P’s<0.01: 
Fig. 1A-D) and no effects on the contralateral side (F=3.532, P= n.s.). 
Interestingly, in animals with EFs, the proliferating cells showed a clear 
migration, already at the level of the SVZ, moving from the ventral 
towards the dorsal parts. To evaluate whether the migration continued 
towards the cortical area below the electrode, we determined the number 
of BrdU labeled cells there (supplementary material). We found a 
remarkable increase in the number of BrdU cells in the cortical area below 
the electrodes, in the animals with epidurally applied EFs (F=8.714, 
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P’s<0.05: Fig. 1E). In the contralateral cortex, we found no increase 
(F=0.003, P=n.s.). We double-labeled these migrated newborn cell with 
NeuN, a marker for neuronal phenotype (supplementary material). We 
found significantly more cells with a neuronal phenotype in animals with 
epidurally applied EFs (F=7,642, P<0.05; Fig. 1F-G).  
 
The fifth step was to control for the possibility that migration of newborn 
cells from the SVZ to the area with EFs goes at the cost of the 
physiological migration towards the olfactory bulb. We assessed the 
number of newborn cells in the olfactory bulb, and found no differences 
between groups (F=1.906, P=n.s.; Fig. 2A). 
 
The mechanism responsible for effects described here certainly need 
further investigation, but at the moment can be discussed in at least three 
domains, proliferation, migration and differentiation. Although the latter 
two are largely unknown,   effects of stimulation on proliferation have 
been described (Toda et al., 2008). Based on our interest in the 
subependymal 5-HT (5-hydroxytryptamine, serotonin) fiber plexus 
(Jahanshahi et al., 2011) distributed within areas of the SVZ with stem- 
and progenitor cells and the well-known effects of 5-HT on neurogenesis 
(Banasr et al., 2004; Brezun and Daszuta, 1999), we reasoned here that 
enhanced 5-HT in the SVZ would be responsible for the boost in 
proliferation. In our final experiment, using a double-labeling study 
(supplementary material), we found clearly enhanced 5-HT fibers in the 
SVZ in animals with epidurally applied EFs (F=27.473, P’s<0.01: Fig. 2B-
D). Since 5-HT innervation of the SVZ, comes mainly from the 5-HT cells 
in the dorsal raphe nucleus (DRN) (Jahanshahi et al., 2011), we 
investigated its neuronal activity (supplementary material) and found a 
substantial increase (F=27.992, P’s<0.01: Fig. 2F-G).   
 
Our findings demonstrated the in vivo existence of electrotaxis (McCaig et 
al., 2005) (ie. attracting cells with electrical currents), which can 
apparently occur the normal migration. It was accompanied by an 
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increased production of new cells and enhanced differentiation into 
neurons. This mechanism offers new perspectives for brain repair.  
 
 
Materials and methods 
 
Electrode construction 
The electrodes were designed and manufactured by us with the assistance 
of our medical engineering department. The total size of the construction 
is 3mm x 3mm and made up of a base material and two layers of copper. 
The base material has a thickness of 0.36mm and both copper layers have 
a thickness of 18µm. The copper layers are covered with a Ni/Au coating. 
It consists of one central rectangle part (2,5mmx1mm) for the connection 
of a wire and 6 round electrode contacts (0,75mm in diameter). 
  
Subjects and experimental groups 
Male Sprague Dawley weighing approximately 300 g at the time of 
surgery were housed individually (Central Animal Facility of Maastricht 
University, Maastricht, The Netherlands) under a 12-h reversed light/dark 
cycle, with food and water freely available. All experimental procedures 
were approved by the Animal Experiments and Ethics Committee of 
Maastricht University. 
 
Rats were randomly assigned to one of the following groups: Sham (n= 6), 
low frequency stimulation (LFS, n= 6) or high frequency stimulation 
(HFS, n= 6). 
 
Surgical procedure 
The surgical procedures were performed under general anesthesia using 
isoflurane. Body temperature was controlled and supported. Rats 
underwent craniotomy (3.5mm × 3.5mm) on the right hemisphere above 
the sensorimotor cortex (M1 and M2 cortices), coordinates from Bregma: 
AP 0.0mm to 3.5mm and ML 0.0mm to 3.5mm (Paxinos and Watson, 
1998). All animals received implantation of the electrode construction 
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epidurally and a monopolar reference electrode was placed in the skull 
above the left hemisphere (Paxinos and Watson, 1998). Stainless steel 
screws were also positioned in the skull above the parietal and occipital 
bones and served as anchoring arms. All electrodes were connected to pins 
of a lightweight miniature socket as a head-stage and fixed to the skull 
with dental acrylic. Afterwards, animals received a 2-week recovery 
period. 
 
Stimulation parameters 
For a period of 31 days, each animal was stimulated in a freely moving 
condition 4 h per day. During the stimulation rats had free access to food 
and water. We applied a pulse width of 60 μs, LFS (30 Hz) and HFS (330 
Hz). The pulse amplitude was 50% of the amplitude inducing a 
contralateral motor response. A World Precision Instruments accupulser 
(A310, WPI, Berlin, Germany) and a stimulus isolator (A360, WPI, 
Berlin, Germany) were used to deliver the stimuli. Sham operated animals, 
were connected to the stimulator but not stimulated spent the same time in 
the cage. 
 
BrdU administration and tissue processing 
For a period of five days before the stimulation started, all rats received 
twice daily with a minimum interval of 6 h, intraperitoneal injections of 
the thymidine analog 5bromo-2deoxyuridine (BrdU, 50 mg/kg, Sigma, St. 
Louis, MO, U.S.A.), 2 mg/ml in 0.9% saline (pH 7.6). At the end of the 
stimulation period, animals received an overdose of Nembutal
®
, and 
underwent perfusion-fixation with tyrode (0.1 M) and fixative containing 
4% paraformaldehyde, 15% picric acid, 0,05% glutaraldehyde in 0.1 M 
phosphate buffer (pH 7.6). Brains were removed and post-fixed for 2 h 
followed by overnight immersion in 15% sucrose at 4 °C. Brain tissue was 
then quickly frozen with CO2, stored at −80 °C and later cut serially using 
a cryostat. 
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Immunohistochemical staining 
To assess cell proliferation one series of brain sections was processed 
immunohistochemicaly for Ki-67, a well characterized protein extensively 
used as a proliferation marker (Scholzen and Gerdes, 2000). In addition, to 
evaluate the density of 5-HT-immunoreactive (5HT-IR) neuronal fibers in 
the SVZ and motor cortex, two series of sections containing the SVZ and 
motor cortex were processed for 5-HT immunohistochemistry. Another 
series of sections containing the olfactory bulbs (OB) were processed 
immunohistochemicaly for BrdU. Finally, to test the effect of EFs on DRN 
cells, we carried out c-Fos (K-25) immunohistochemistry. C-Fos (K-25) is 
known to be a marker for neuronal activation (Budzikowski et al., 1998). 
 
The stainings were carried out using primary antibodies; rabbit anti-Ki-67 
(diluted 1:1000, Vector laboratories, Inc, USA), rabbit anti-5-TH antibody 
(Steinbusch, 1981), (diluted 1:20000) mouse anti-BrdU (1:400, Roche, IN, 
USA) and polyclonal rabbit anti-c-Fos (K-25) (1:10,000; Santa Cruz 
Biotechnology Inc, Santa Cruz, USA). After the incubation period (three 
days for 5-HT and overnight for the rest) and rinsing steps with TBS and 
Tris-buffered solution containing Triton X-100 (TBS-T), and incubation 
with the secondary antibody (1:800 donkey anti-rabbit biotin and donkey 
anti-mouse biotin, Jackson Immunoresearch Laboratories, West Grove, 
USA), the sections were incubated for two hours with an avidin-biotin-
peroxidase complex (1:800, Vector laboratories, Inc, USA). To visualize 
the horseradish peroxide reaction product, the sections were incubated 
with 3,3′ -diaminobenzidine tetrahydrochloride. Finally, the sections were 
mounted and coverslipped. 
 
To evaluate neuronal differentiation, another series of tissue sections 
containing the motor cortex were processed for BrdU and NeuN double 
staining. Staining was performed using the primary antibodies mouse anti-
BrdU (1:400) and mouse anti-NeuN (biotin-conjugated; 1:100, Temecula, 
California, USA). After overnight incubation and washing steps, brain 
sections were incubated with the secondary anitibodies donkey-anti-mouse 
alexa 488 (1:200, Invitrogen, Oregon, USA) and streptavidin alexa 594 
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(1:1000, Invitrogen, Oregon, USA). Sections were washed, mounted on 
gelatine coated glasses and coverslipped with 80% glycerol in TBS.   
 
Quantification of immunohistochemical data 
Ki-67 cells in the SVZ 
The number of Ki-67 containing cells in the SVZ was quantified using 
designed based stereology. Stereological investigations were carried out 
with a stereological computer microscopy system (Stereo Investigator, 
Microbrightfield Bioscience, Williston, VT). In all sections showing the 
SVZ, the region comprising the Ki-67 containing cells in the SVZ, was 
delineated and total numbers of Ki-67 containing cells was estimated with 
the optical fractionator method (Schmitz and Hof, 2000; Schmitz and Hof, 
2005; West et al., 1991). Our stereological counting method has been 
previously described (Temel et al., 2006). 
 
BrdU/NeuN double-labeled cells in the cortex    
Double-stained sections were evaluated using a spinning disk confocal 
microscope (Olympus DSU BX51WI, Pennsylvania, USA) connected to a 
computer with analysis software (Stereo Investigator, Microbrightfield 
Bioscience, Williston, VT). Per brain, three sections from three bregma 
levels (+3.20, +2.20 and +1.20, according to the atlas of the rat brain 
(Paxinos and Watson, 1998), were used for cell counting. After delineating 
the M1/M2 cortex, all BrdU-labeled cells were assessed and also the 
number of double labeled cells with NeuN.  
 
BrdU cells in the olfactory bulb 
Three sections per rat were quantified at the right and left mid-olfactory 
bulb levels using an image analysis system (analySIS Imaging System, 
Munster, Germany) from digital photos taken by an Olympus U-CMAD-2 
digital camera connected to an Olympus AX-70 microscope. Four 
olfactory bulb areas (dorsal, ventral, medial, lateral) from the granular 
layer of each section were randomly chosen from each side using the 20× 
magnification (Fig; 5-C). Cells were counted in each photomicrograph 
using ImageJ software (version 1.38x; National Institutes of Health, 
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Bethesda, MD, USA). Quantification method for OB was adopted from an 
earlier publication (Sundholm-Peters et al., 2005). 
 
Density of 5-TH containing fibers in the SVZ  
The optical density of 5-TH containing fibers in the in the SVZ were 
quantified using an image analysis system (f-view; Olympus, Tokyo, 
Japan) connected to an Olympus AX70 brightfield microscope (analySIS; 
Imaging System, Münster, Germany) from digital photos taken by an 
Olympus U-CMAD-2 digital camera connected to an Olympus AX 70 
microscope. Densitometric measurements using the ImageJ software were 
obtained at 3 anteroposterior levels for in the right and left hemispheres. 
The coordinates were from bregma for the SVZ +0.48, +0.20 and -0.40 
(Paxinos and Watson, 1998). Data are expressed as optical density ratios.  
 
c-Fos cells in the DRN 
Images of the area of interest were taken. The number of c-Fos containing 
cells were counted using a previously described method (Tan et al., 2011). 
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In the present thesis, we first investigated the plasticity of the 
intracellular contents (phenotype) of different neurotransmitters in the 
dorsal raphe nucleus (DRN) following pharmacological modulation. 
Secondly, we aimed to find the consequence of genetic modulation on the 
serotonergic and dopaminergic systems. In addition, we provided a review 
of the histology, anatomy, and chemistry of the subventricular zone 
(SVZ). In this chapter, we outlined the involvement of the neurogenic 
SVZ serotonergic system in neurogenesis, which can be considered as 
structural plasticity. Following this, we developed a new method to 
influence neurogenesis by a 5-HT related mechanism. The experimental 
data presented in this thesis are, in summary, as follows; 
 
Pharmacological modulation, using buspirone, a 5-HT1A partial 
agonist, administered intra-peritoneal, resulted in neurochemical changes 
in the DRN. We have shown that buspirone has an effect on different 
neurotransmitter systems in the DRN, while the mechanism of action is 
explained by an effect on the serotonergic (5-hydroxytryptamine- 5-HT) 
system. Here, we investigated the effect of acute and chronic buspirone 
treatment on the 5-HT and non-5-HT cells, the neuronal nitric oxide 
synthase (nNOS) and tyrosine hydroxylase (TH) cells, in the DRN. Our 
findings suggest that buspirone treatment affects not only the phenotype of 
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5-HT but also of nNOS and TH. Taken together, our findings provide 
additional evidence that the 5-HT and dopamine systems are remarkably 
interrelated in the DRN. In addition, our findings of acute and chronic 
effects of nNOS, suggest that this enzyme responsible for NO production 
can be activated during any moment of physiological response. Therefore, 
the cellular effects of buspirone are more complex than thought. 
 
Although the abnormalities in serotonergic neurotransmission are 
known to be associated with depressive and anxiety symptoms, other 
neurotransmitter systems have also been shown to be involved. Using 
three genetically modified mouse models, all characterized by altered 
behaviors in depression-related paradigms, our results show quantitative 
differences in tryptophan hydroxylase-2 (TPH2) mRNA expression in the 
three main subregions of the DRN as well as in the median raphe nucleus 
(MRN). These changes are related to serotonergic or glutamatergic 
neurotransmission and to endocannabinoid systems. It appears that TPH2 
mRNA levels and activity can be regulated by the end-product 5-HT. In 
particular; higher extracellular 5-HT levels result in lower TPH mRNA 
expression in 5-HT transporter knock-out mice (5-HTT-/-). In addition, we 
found that cannabinoid receptor knock out (CB1R -/-) and vesicular 
glutamate transporter-1 (VGLUT1) genetic manipulation could lead to 
distributions in the excitatory and inhibitory effect exerted throughout 
different receptor types not only in the DRN and MRN 5-HT neurons, but 
also in target brain regions, possibly leading to impaired serotonergic 
negative feedback. These can enhance the expression of TPH2 mRNA in 
the DRN. Based on the findings of the present study, we suggest that 
TPH2 mRNA expression is under the influence of multiple messenger 
systems in relation with presynaptic and/or postsynaptic feedback control 
of serotonin synthesis. 5-HTT, VGLUT1 and CB1R seem to be involved 
in the execution of these feedback mechanisms. Finally, our data are 
consistent with previous reports suggesting that TPH2 activity, within 
different raphe subregions are differentially regulated under specific 
conditions. 
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In another set of experiments we studied the effect of genetic 
modulation on dopaminergic system neuroplasticity. In this respect, using 
a recently generated transgenic rat model of Huntington’s disease (tgHD), 
which shows progressive striatal neurodegeneration and chorea, we have 
found evidence for increased levels of dopamine in the striatum, which is 
in line with post-mortem human studies. In addition, we have 
demonstrated that the origin of increased levels of dopamine is the 
presence of more dopaminergic cells in the ventral tegmental area (VTA) 
and the substantia nigra pars compacta (SNc) of transgenic Huntington’s 
disease rats, the two main nuclei providing the striatum with dopamine. 
Here we suggested that the increased number of tyrosine hydroxylase (TH) 
containing cells in the SNc and VTA is possibly due to the change in 
phenotype of the non-TH containing cells. Our finding provides additional 
evidence for the observations concerning the treatment of the chorea with 
dopamine-antagonists and dopamine-depleting drugs. In addition, these 
findings are in line with previous experimental studies showing that high 
concentration of dopamine in the striatum leads to neurotoxicity and may 
play a role in the neurodegeneration in HD. 
 
 
To further investigate the mechanism(s) underling the 
hyperdopaminergic status in HD, we studied the DRN, the main area of 
dopaminergic and non-dopaminergic neurons outside the SNc and VTA, 
which could contribute to the dopaminergic input to the basal ganglia. 
Since we found no clear evidence for changes in the total cell numbers in 
the investigated regions, we hypothesized that this increase may be due to 
the change in the phenotype of the non-dopamine containing cells. 
Importantly, in addition to the tgHD rats, we found this 
hyperdopaminergic status also in the DRN tissue of HD patients, 
establishing a consistency of the finding across species. Based on these 
findings we suggest that the mutation in HD causes neurons to switch 
phenotypes, which may underlie the clinical neurological symptoms and 
provide a novel mechanism for therapy development. 
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Altered neurogenesis is among the most prominent forms of 
neuroplasticity, which has been shown to be regulated by serotonergic 
inputs. The presence of a dense 5-HT fiber complex in the vicinity of the 
stem/progenitor cells of the SVZ is an intriguing anatomical fact. This 
close anatomical relationship suggests an important functional role for 5-
HT in influencing cell proliferation in the SVZ. However, it remains 
unsolved how 5-HT released by terminals in the subependymal complex 
reaches the cells in the SVZ. There are two possibilities: direct synaptic 
contact or diffusion. Synaptic contact has not been found, but we have to 
bear in mind that it has not been investigated in detail yet. Diffusion of 5-
HT to the neighboring stem cells is a plausible mechanism. It might well 
be that both mechanisms exist and are activated depending on the action 
required. In this respect, evidence suggest a fine-tuning effect of 5-HT on 
cell proliferation, enhanced by lower concentrations and decreased by 
higher levels.  
 
During the last decades electrical modulation of central nervous 
system (CNS) has attracted great deal of interest in symptomatical 
treatment of a variety of neurological disorders. However, the mechanism 
by which electrical stimulation of CNS exerts therapeutic effects is not 
known yet. Here, we successfully developed a new tool to influence adult 
brain plasticity using electrical stimulation. We aimed to enhance the 
migration of neuronal progenitor cells towards the motor cortex, so called 
“electrotaxis”. We found that epidural electrical stimulation of the motor 
cortex induced an increase in SVZ neurogenesis and migration. We found 
that these effects were accompanied by an enhanced 5-HT system.  
 
 
 The results obtained from the experiments as outlined in this thesis 
show that the serotonergic and dopaminergic systems undergo various 
plastic changes following pharmacological, genetic and electrical 
neuromodulation. Beside the conventional form of synaptic plasticity, 
which is achieved through enhancing communication at the synaptic site 
between existing neurons, for a long time the notion of structural forms of 
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neuronal plasticity in the adult brain were considered heretic. In recent 
years, the existence of neurogenesis has become scientifically established. 
In this thesis, we have found evidence for radical forms of neuronal 
plasticity, namely the change in the phenotype of neurons and electrotaxis 
of neuronal stem cells in the adult brain. Based on these findings we 
suggest that in the presence of disease-related deficits and impaired 
synaptic plasticity, seen in behavioral disorders, the brain once again 
manifests its multi-source plasticity by re-organizing its resources. The 
challenge is to find tools to enhance this capacity, which ultimately can be 
a remedy for (degenerative) brain disorders. 
 
 143 
Acknowledgments 
 
I want to thank the following people for their support and help 
in the completion of this thesis. 
 
Prof. Dr. Harry W. M. Steinbusch 
Dear Harry, during my last year of master training, I contacted 
you to ask about the possibility to perform research at your 
department; you gave me this opportunity and opened the doors to 
science for me. Ever since, you have provided me continuous 
guidance and support throughout this period of scientific research. 
You played and are still playing a very important role in my 
academic development. I consider this as a great privilege and 
cannot thank you enough for your support. 
 
Prof. Dr. Y. Temel 
Dear Yasin, my heartfelt gratitude for your sustained guidance, 
patience and supports you have provided throughout my time as your 
PhD student. I consider myself extremely fortunate for being able to 
work with you and having a supervisor who cared so much, not only 
about my research over this PhD period, but also about my future 
research career. Yasin: I will always keep this in my mind that “good 
scientist needs to be a good writer as well”. 
 
Prof. Dr. T. Hokfelt 
Dear Tomas, you gave me the opportunity to learn in-situ 
hybridization in your laboratory and enjoy the great scientific 
atmosphere of the Karolinska Institute. You and your group taught 
me wonderful things. I would like to express my sincere appreciation 
to you and the members of your group. I am looking forward to 
future collaborations. 
 
Prof. Dr. D. Hopkins 
My acknowledgments of gratitude would also be mentioned to 
Prof. Dr. David Hopkins, for your inspiration, guidance and careful 
perusal of this thesis. 
Acknowledgments  
 
144 
Dr.  Hoogland 
Dear Govert, many thanks to you for your supports and 
consistent attention when I was faced with a challenge. You always 
helped me in exchanging any ideas and gave me invaluable 
comments and critiques on the improvement of my work.  
 
My homeland mentors  
A word of thank-you would also be expressed to Mr. Hossein 
Radmard; enjoying your lessons in high school led me to my love of 
biology. Dr. Komaki: with you, I experienced my first in-vivo and 
ex-vivo experiments using old fashioned physiograph equipment 
during my bachelor studies! Prof. Mirnajafi-zadeh, Prof. Javan, Prof. 
Semnanian and Prof. Fathollahi: I feel deeply honored to start 
studying neuroscience with you.  
 
Dr. L. Lee Wei  
Dear Anthony, you were my first friend in Maastricht. You 
helped me out enormously in my research. Without your 
commitment, it was not possible to accomplish this project in the 
way we did. I want to thank you for your help and wish you good 
luck with your career. 
 
HE. Steinbusch, M. Philippens and D. hermes 
Dear Hellen, Denise and Marjan, I believe that without your 
technical supports the lab would not work. I thank you very much for 
your help and support. 
 
Colleagues 
The acknowledgements would not be complete without 
thanking my colleagues (as well as my sub-family members) of the 
experimental neurosurgery group. Rinske, Sonny, Mark, Youssef, 
Thibaut, Dagmar, Sarah, Mujzgan, Ehsan, Ingeborg, Maartje, 
Syenna, Frederic, Thank you for your unconditional support and help 
not only for my research but also for our excellent and wonderful 
relationship. I really appreciate everything you have done for me and 
 145 
my gratitude to all of you is beyond description! Rinske and Mark, 
thank you once again for being my ‘Paranimfen’ in organizing this 
successful event. Besides, I would like to thank Ahmet and Ersoy for 
your contribution in creating an ideal and interactive environment of 
science in the experimental neurosurgery group.  
 
I would like to thank my colleagues and friends of the 
department for maintaining a good research environment. Here, my 
heartfelt gratitude to Prof. Marc De Baets, Prof. Fred van Leeuwen, 
Dr. Jos Prickaerts, Dr. Arjan Blokland, Dr. Jodi Pawluski, Prof. Bert 
Joosten, Dr. Ronald Deumens, Dr. Daniel van den Hove, Dr. Mario 
Losen, Dr. Pilar Martinez, Dr. Bart Rutten, Wiel, Sajjad, Shahed, 
Frank, Bart, Gerard, Pablo, Leonidas, Marlien, Marisela, Anna, 
Marijke, Annerieke, Natalia, Chiara, Alejandro, Tim, Sven and 
others. A special thank is also extended Marjanne Markerink for 
your excellent technical support in the laboratory. My sincere 
gratitude is also owed to Dr. Nicole Senden, Marie-Therese Moers, 
Liza pizuto,  Anja de Bruin, for your wonderful secretary works in 
the department; as well as Ankie Hochstenbach, Laurent Louwies, 
and Marko van Hertrooy for your financial coordination. A word of 
thank-you would also be expressed to Richard Frijnts, Dr. Saskia 
Seeldrayers, Rik Tinneman, Clarice Soogelee and all CPV members. 
 
On a more personal note, my acknowledgment of gratitude 
would also be mentioned to my parents and my brothers. They have 
always loved me and supported every choice of me. For sure, they 
are the happiest and the most proud persons, when seeing me getting 
this degree, I indeed dedicate this book to them. 
 
A special thank is extended to the board of evaluation 
committee and corona of my dissertation defense for asking 
insightful questions and providing useful comments on the 
presentation of this scientific report.   
Acknowledgments  
 
146 
Many people in one way or another contributed to this thesis. It 
may be that I'm forgetting some people. I want to thank everyone 
who contributed. All deserve my deepest heartfelt gratitude. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biography 
 
147 
Biography 
 
Ali Jahanshahi was born on 23
nd
 of September, 1978 in Bahar, a small city 
located in the mountainous province of Hamedan in western Iran. 
He studied nursing at Hamedan University of Medical Sciences. 
Thereafter, he worked as a nurse in the trauma emergency unit from June 
2002 to September 2005. Being interested in biology urged him to 
continue his academic education in the field of basic sciences. During his 
master study, he worked as a student-assistant at the department of cellular 
neurosciences under the supervision of Prof. Dr. Harry Steinbusch and Dr. 
Yasin Temel. In 2007, he received his master degree in medical 
physiology (with specialization in neurophysiology) at the Tarbiat 
Modares University in Tehran, Iran. In December 2008, he was awarded 
with Marie Curie fellowship to carry out his PhD research at the 
department of Neuroscience, Maastricht University, the Netherlands. 
Within this period he spent four months as a guest researcher under the 
supervision of Prof. Dr. Tomas Hokfelt at the department of neuroscience, 
Karolinska Institute, Stockholm, Sweden. 
 
 
  
 
  
 
 149 
List of publications 
 
 
1. Temel Y, Zeef DH, Janssen ML, Oosterloo M, Schaper F, Jahanshahi A, 
Vlamings R. Lessons learned from the transgenic Huntington's disease rats. 
Neural Plast, 2012 
 
2. Janssen ML, Zwartjes DG, Tan SK, Vlamings R, Jahanshahi A, Heida T, 
Hoogland G, Steinbusch HW, Visser-Vandewalle V, Temel Y. Mild 
dopaminergic lesions are accompanied by robust changes in subthalamic nucleus 
activity. Neurosci Lett, 2011 
 
3. Jahanshahi A, Temel Y, Steinbusch HW. Dissecting the projections of different 
groups of raphe serotonergic neurons (Commentary on Beng et al.). EUR J 
Neurosci, 2011 
 
4. Zeef DH, van Goethem NP, Vlamings R, Schaper F, Jahanshahi A, Hescham S, 
von Hörsten S, Prickaerts J, Temel Y. Memory deficits in the transgenic rat 
model of Huntington's disease. Behav Brain Res. 2011 Nov 15 
 
5. Zeef DH, Vlamings R, Lim LW, Tan S, Janssen ML, Jahanshahi A, Hoogland 
G, Prickaerts J, Steinbusch HW, Temel Y. Motor and non-motor behaviour in 
experimental Huntington's disease. Behav Brain Res. 2011  
 
6. Jahanshahi A, Temel Y, Lim LW, Hoogland G, Steinbusch HW; Close 
communication between the subependymal serotonergic plexus and the 
neurogenic subventricular zone. Journal of Chem neuroanat, 2011 
 
7. Jahanshahi A, Le Maitre E, Temel Y, Lanfumey L, Hamonf M, Lesch P, 
Tordera, RM, Del Río J, Aso E, Maldonado R, Hökfelt T, Steinbusch HW; 
Altered expression of neuronal tryptophan hydroxylase-2 mRNA in the dorsal 
and median raphe nuclei of three genetically modified mouse models relevant to 
depression and anxiety. Journal of Chem neuroanat, 2011 Jul; 41(4):227-33 
 
8. Tan SK, Janssen ML, Jahanshahi A, Chouliaras L, Visser-Vandewalle V, Lim 
LW, Steinbusch HW, Sharp T, Temel Y; High frequency stimulation of the 
subthalamic nucleus activates dorsal raphe afferent nuclei and inhibits dorsal 
raphe nucleus activity; a combined morphological and behavioural study. J 
Psychiatr Res, 2011  
 
9. Lim LW, Blokland A, Duinen M, Tan S, Vlamings S, Janssen M, Jahanshahi 
A, Aziz-Mohammadi M, Steinbusch H, Schruers K,Temel Y; Increased plasma 
corticosterone levels after periaqueductal gray stimulation-induced escape 
reaction or panic attacks in rats. Behav Brain Res, 2010 15; 218(2):301-7 
 
Publications 
 
 
150 
10. Jahanshahi A, Vlamings R, Hilmi Kaya A, Lim LW, Janssen M.L.F, Tan S.K, 
Visser-Vandewalle V, Steinbusch H.W.M, Temel T; Hyperdopaminergic status 
in experimental Huntington’s disease. J Neuropath Exp Neurol, 2010 Sep; 69 
(9): 910-7 
 
11. Jahanshahi A, Lim LW, Steinbusch HWM, Visser-Vandewalle V, Temel Y; 
Buspirone-induced changes in the serotonergic and non-serotonergic cells in the 
dorsal raphe nucleus of rats. Neuroscience Letters, 2010 Apr 5; 473(2):136-40 
 
12. Mehregan H, Sadeghizadeh M, Zarrindast MR, Jahanshahi A, Shirzad H, 
Saadati M; Effect of Morphine-Sensitization in D2 Receptor Gene Expression in 
the Mice Brain in the Absence and Presence of Lithium Chloride. Yakhteh 
Medical Journal, Vol 12, No 3, 2010, Pages: 395-404 
 
13. Jahanshahi A, Mirnajafi-Zadeh J, Javan M, Mohammad-Zadeh M, Rohani 
R;The antiepileptogenic effect of electrical stimulation at different low 
frequencies is accompanied with change in adenosine receptors gene expression 
in rats. Epilepsia. 2009 Apr 24. 
 
14. Mohammad-Zadeh M, Mirnajafi-Zadeh J, Fathollahi Y, Javan M, Jahanshahi 
A, Noorbakhsh SM, Motamedi F; The role of adenosine A(1) receptors in 
mediating the inhibitory effects of low frequency stimulation of perforant path 
on kindling acquisition in rats. Neuroscience. 2009 Feb 18; 158(4): 1632-43. 
 
15. Sadegh M, Mirnajafi-Zadeh J, Javan M, Fathollahi Y, Mohammad-Zadeh M, 
Jahanshahi A, Noorbakhsh SM; The role of galanin receptors in anticonvulsant 
effects of low-frequency stimulation in perforant path-kindled rats. 
Neuroscience. 2007 Dec 5; 150(2): 396-403. 
 
 
 
Submitted manuscripts 
 
1. Jahanshahi A, Janssen ML, Steinbusch HW and Temel Y. In vivo brain repair? 
Electrical fields attract newborn brain cells. 
 
2. Jahanshahi A, Vlamings A, van Roon-Mom W. Faull R.L.M, Waldvogel H.J, 
Steinbusch H.W.M, Temel Y. “Phenoconversion” in experimental and clinical 
Huntington’s disease 
 
 
 
 
 
